| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.806 | 0.004 | 0.806 | 5 Hydroxytryptamine release stimulant | 0.715 0.006 DBMET00534 0.402 0.045 DBMET00565 0.402 0.045 DBMET00573 0.731 0.005 DBMET00587 0.802 0.004 DBMET00614 | ||
| 0.696 | 0.004 | 0.768 | Superoxide dismutase inhibitor | 0.71 0.004 DBMET00534 0.768 0.003 DBMET00565 0.768 0.003 DBMET00573 0.22 0.097 DBMET00587 0.554 0.009 DBMET00614 | DBMET00573 | |
| 0.691 | 0.001 | 0.691 | Phenylalanine 4-hydroxylase inhibitor | 0.539 0.002 DBMET00534 0.453 0.003 DBMET00565 0.453 0.003 DBMET00573 0.213 0.006 DBMET00587 0.439 0.003 DBMET00614 | ||
| 0.662 | 0.012 | 0.662 | Aldehyde oxidase inhibitor | 0.627 0.015 DBMET00534 0.153 0.136 DBMET00565 0.153 0.136 DBMET00573 0.513 0.031 DBMET00614 | ||
| 0.65 | 0.003 | 0.65 | Tyrosine 3 hydroxylase inhibitor | 0.479 0.004 DBMET00534 0.331 0.021 DBMET00565 0.331 0.021 DBMET00573 0.204 0.129 DBMET00587 0.491 0.004 DBMET00614 | ||
| 0.634 | 0.002 | 0.634 | Glutamate decarboxylase inhibitor | 0.536 0.002 DBMET00534 0.266 0.004 DBMET00565 0.266 0.004 DBMET00573 0.151 0.013 DBMET00587 0.354 0.003 DBMET00614 | ||
| 0.611 | 0.004 | 0.611 | Peroxidase inhibitor | 0.606 0.004 DBMET00534 0.407 0.02 DBMET00565 0.407 0.02 DBMET00573 0.444 0.015 DBMET00614 | ||
| 0.57 | 0.003 | 0.57 | 5 Hydroxytryptamine uptake stimulant | 0.511 0.004 DBMET00534 0.314 0.038 DBMET00565 0.314 0.038 DBMET00573 0.236 0.095 DBMET00587 0.513 0.004 DBMET00614 | ||
| 0.557 | 0.003 | 0.557 | GABA C receptor agonist | 0.557 0.003 DBMET00534 0.175 0.026 DBMET00565 0.175 0.026 DBMET00573 0.128 0.045 DBMET00587 0.496 0.004 DBMET00614 | ||
| 0.569 | 0.041 | 0.616 | Caspase 9 stimulant | 0.616 0.034 DBMET00534 0.57 0.041 DBMET00587 0.572 0.04 DBMET00614 | DBMET00534 | |
| 0.496 | 0.011 | 0.496 | Psychostimulant | 0.48 0.013 DBMET00534 0.493 0.011 DBMET00587 0.456 0.015 DBMET00614 | ||
| 0.489 | 0.017 | 0.683 | Free radical scavenger | 0.59 0.009 DBMET00534 0.376 0.033 DBMET00565 0.376 0.033 DBMET00573 0.683 0.005 DBMET00587 0.302 0.051 DBMET00614 | DBMET00587 | |
| 0.473 | 0.003 | 0.473 | Carbonic anhydrase XV inhibitor | 0.438 0.004 DBMET00534 0.351 0.005 DBMET00565 0.351 0.005 DBMET00573 0.123 0.045 DBMET00587 0.356 0.005 DBMET00614 | ||
| 0.503 | 0.04 | 0.584 | 15-Lipoxygenase inhibitor | 0.584 0.026 DBMET00534 0.443 0.056 DBMET00565 0.443 0.056 DBMET00573 0.423 0.065 DBMET00614 | DBMET00534 | |
| 0.468 | 0.007 | 0.558 | Phospholipase C inhibitor | 0.414 0.009 DBMET00534 0.558 0.005 DBMET00565 0.558 0.005 DBMET00573 0.341 0.015 DBMET00587 0.32 0.017 DBMET00614 | DBMET00573 | |
| 0.458 | 0.003 | 0.499 | Histidine decarboxylase inhibitor | 0.499 0.003 DBMET00534 0.097 0.033 DBMET00565 0.097 0.033 DBMET00573 0.113 0.028 DBMET00587 0.356 0.005 DBMET00614 | DBMET00534 | |
| 0.476 | 0.027 | 0.651 | Spasmolytic | 0.487 0.025 DBMET00534 0.352 0.052 DBMET00565 0.352 0.052 DBMET00573 0.651 0.009 DBMET00587 0.389 0.042 DBMET00614 | DBMET00587 | |
| 0.492 | 0.045 | 0.849 | Transcription factor NF kappa B inhibitor | 0.54 0.039 DBMET00534 0.351 0.077 DBMET00565 0.351 0.077 DBMET00573 0.849 0.01 DBMET00587 0.385 0.067 DBMET00614 | DBMET00587 | |
| 0.481 | 0.039 | 0.56 | 5 Hydroxytryptamine release inhibitor | 0.404 0.076 DBMET00534 0.56 0.017 DBMET00587 0.504 0.031 DBMET00614 | DBMET00587 | |
| 0.471 | 0.034 | 0.493 | GABA C receptor rho-3 antagonist | 0.493 0.028 DBMET00534 0.485 0.03 DBMET00614 | DBMET00534 | |
| 0.433 | 0.004 | 0.433 | Carbonic anhydrase VI inhibitor | 0.334 0.005 DBMET00534 0.381 0.004 DBMET00565 0.381 0.004 DBMET00573 0.267 0.008 DBMET00587 0.27 0.008 DBMET00614 | ||
| 0.436 | 0.02 | 0.526 | Amyloid beta aggregation inhibitor | 0.526 0.012 DBMET00534 0.189 0.084 DBMET00565 0.189 0.084 DBMET00573 0.323 0.041 DBMET00587 0.326 0.04 DBMET00614 | DBMET00534 | |
| 0.441 | 0.028 | 0.706 | Antioxidant | 0.561 0.014 DBMET00534 0.554 0.015 DBMET00565 0.554 0.015 DBMET00573 0.706 0.005 DBMET00587 0.274 0.072 DBMET00614 | DBMET00587 | |
| 0.4 | 0.001 | 0.4 | Dopamine D5 agonist | 0.283 0.001 DBMET00534 0.139 0.003 DBMET00565 0.139 0.003 DBMET00573 0.046 0.021 DBMET00587 0.201 0.002 DBMET00614 | ||
| 0.425 | 0.028 | 0.639 | Vasodilator, coronary | 0.387 0.04 DBMET00534 0.195 0.187 DBMET00565 0.195 0.187 DBMET00573 0.639 0.006 DBMET00587 0.427 0.028 DBMET00614 | DBMET00587 | |
| 0.447 | 0.052 | 0.447 | Calcium channel L-type activator | 0.309 0.15 DBMET00534 0.24 0.217 DBMET00587 0.446 0.053 DBMET00614 | ||
| 0.399 | 0.005 | 0.401 | M18 aspartyl aminopeptidase inhibitor | 0.401 0.005 DBMET00534 0.179 0.04 DBMET00565 0.179 0.04 DBMET00573 0.14 0.057 DBMET00587 0.217 0.029 DBMET00614 | DBMET00534 | |
| 0.44 | 0.055 | 0.613 | Histamine release inhibitor | 0.412 0.069 DBMET00534 0.382 0.085 DBMET00565 0.382 0.085 DBMET00573 0.613 0.009 DBMET00587 0.364 0.093 DBMET00614 | DBMET00587 | |
| 0.384 | 0.019 | 0.407 | Anesthetic general | 0.335 0.026 DBMET00534 0.407 0.015 DBMET00587 0.307 0.031 DBMET00614 | DBMET00587 | |
| 0.374 | 0.01 | 0.437 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.437 0.006 DBMET00534 0.154 0.14 DBMET00565 0.154 0.14 DBMET00573 0.331 0.016 DBMET00587 0.369 0.01 DBMET00614 | DBMET00534 | |
| 0.391 | 0.028 | 0.407 | Calcium channel activator | 0.354 0.047 DBMET00534 0.229 0.173 DBMET00565 0.229 0.173 DBMET00573 0.407 0.022 DBMET00614 | DBMET00614 | |
| 0.386 | 0.024 | 0.386 | Insulysin inhibitor | 0.354 0.033 DBMET00534 0.26 0.087 DBMET00565 0.26 0.087 DBMET00573 0.353 0.033 DBMET00614 | ||
| 0.365 | 0.004 | 0.365 | Alcohol oxidase inhibitor | 0.235 0.005 DBMET00534 0.056 0.039 DBMET00587 0.245 0.005 DBMET00614 | ||
| 0.364 | 0.004 | 0.374 | Porphobilinogen synthase inhibitor | 0.374 0.004 DBMET00534 0.168 0.017 DBMET00565 0.168 0.017 DBMET00573 0.274 0.006 DBMET00614 | DBMET00534 | |
| 0.358 | 0.004 | 0.369 | Nitric-oxide synthase stimulant | 0.354 0.005 DBMET00534 0.195 0.098 DBMET00565 0.195 0.098 DBMET00573 0.369 0.004 DBMET00587 0.315 0.008 DBMET00614 | DBMET00587 | |
| 0.374 | 0.023 | 0.499 | Interleukin agonist | 0.354 0.028 DBMET00534 0.499 0.009 DBMET00587 0.338 0.033 DBMET00614 | DBMET00587 | |
| 0.392 | 0.051 | 0.638 | Cholesterol antagonist | 0.302 0.09 DBMET00534 0.549 0.025 DBMET00565 0.549 0.025 DBMET00573 0.638 0.014 DBMET00587 0.304 0.088 DBMET00614 | DBMET00587 | |
| 0.349 | 0.01 | 0.349 | 5 Hydroxytryptamine 1E antagonist | 0.297 0.032 DBMET00534 0.222 0.106 DBMET00565 0.222 0.106 DBMET00573 0.341 0.012 DBMET00614 | ||
| 0.343 | 0.005 | 0.391 | Carbonic anhydrase III inhibitor | 0.391 0.004 DBMET00534 0.295 0.005 DBMET00565 0.295 0.005 DBMET00573 0.235 0.011 DBMET00587 0.209 0.015 DBMET00614 | DBMET00534 | |
| 0.373 | 0.036 | 0.474 | Interleukin 2 agonist | 0.373 0.036 DBMET00534 0.233 0.139 DBMET00565 0.233 0.139 DBMET00573 0.474 0.011 DBMET00587 0.354 0.044 DBMET00614 | DBMET00587 | |
| 0.322 | 0.002 | 0.322 | Adenylate cyclase stimulant | 0.295 0.003 DBMET00534 0.308 0.003 DBMET00565 0.308 0.003 DBMET00573 0.239 0.005 DBMET00587 0.274 0.003 DBMET00614 | ||
| 0.396 | 0.079 | 0.701 | Antibacterial | 0.454 0.055 DBMET00534 0.543 0.03 DBMET00565 0.543 0.03 DBMET00573 0.701 0.009 DBMET00587 0.374 0.089 DBMET00614 | DBMET00587 | |
| 0.319 | 0.005 | 0.847 | Carbonic anhydrase XIII inhibitor | 0.361 0.004 DBMET00534 0.847 0.002 DBMET00565 0.847 0.002 DBMET00573 0.444 0.004 DBMET00587 0.205 0.013 DBMET00614 | DBMET00573 | |
| 0.319 | 0.012 | 0.319 | Adenylate cyclase inhibitor | 0.267 0.017 DBMET00534 0.137 0.054 DBMET00565 0.137 0.054 DBMET00573 0.234 0.021 DBMET00587 0.242 0.02 DBMET00614 | ||
| 0.316 | 0.014 | 0.376 | Neurotrophic factor enhancer | 0.335 0.011 DBMET00534 0.376 0.007 DBMET00587 0.246 0.041 DBMET00614 | DBMET00587 | |
| 0.306 | 0.003 | 0.306 | GABA aminotransferase inhibitor | 0.167 0.005 DBMET00534 0.081 0.045 DBMET00565 0.081 0.045 DBMET00573 0.226 0.004 DBMET00587 0.214 0.004 DBMET00614 | ||
| 0.319 | 0.019 | 0.439 | Peptidyltransferase inhibitor | 0.303 0.024 DBMET00534 0.216 0.081 DBMET00565 0.216 0.081 DBMET00573 0.439 0.005 DBMET00587 0.279 0.033 DBMET00614 | DBMET00587 | |
| 0.354 | 0.055 | 0.402 | 12-Lipoxygenase inhibitor | 0.402 0.038 DBMET00534 0.291 0.085 DBMET00614 | DBMET00534 | |
| 0.334 | 0.04 | 0.345 | Transcription factor STAT inhibitor | 0.345 0.036 DBMET00534 0.33 0.041 DBMET00614 | DBMET00534 | |
| 0.304 | 0.012 | 0.315 | NADPH oxidase inhibitor | 0.3 0.013 DBMET00534 0.315 0.01 DBMET00587 0.197 0.035 DBMET00614 | DBMET00587 | |
| 0.294 | 0.005 | 0.331 | 5 Hydroxytryptamine 3E antagonist | 0.267 0.01 DBMET00534 0.195 0.072 DBMET00565 0.195 0.072 DBMET00573 0.331 0.004 DBMET00614 | DBMET00614 | |
| 0.334 | 0.046 | 0.369 | DNA damaging | 0.317 0.051 DBMET00534 0.36 0.038 DBMET00587 0.369 0.035 DBMET00614 | DBMET00614 | |
| 0.297 | 0.01 | 0.314 | Cystathionine beta-synthase inhibitor | 0.314 0.009 DBMET00534 0.265 0.013 DBMET00587 0.203 0.024 DBMET00614 | DBMET00534 | |
| 0.316 | 0.029 | 0.316 | Growth hormone agonist | 0.283 0.036 DBMET00534 0.124 0.115 DBMET00565 0.124 0.115 DBMET00573 0.312 0.03 DBMET00614 | ||
| 0.326 | 0.04 | 0.457 | Vasodilator | 0.359 0.031 DBMET00534 0.457 0.015 DBMET00587 0.243 0.073 DBMET00614 | DBMET00587 | |
| 0.304 | 0.021 | 0.509 | Melanin inhibitor | 0.368 0.014 DBMET00534 0.509 0.006 DBMET00587 0.236 0.031 DBMET00614 | DBMET00587 | |
| 0.345 | 0.066 | 0.764 | Antithrombotic | 0.317 0.078 DBMET00534 0.52 0.026 DBMET00565 0.52 0.026 DBMET00573 0.764 0.005 DBMET00587 0.325 0.074 DBMET00614 | DBMET00587 | |
| 0.294 | 0.017 | 0.491 | Protein kinase stimulant | 0.281 0.02 DBMET00534 0.115 0.098 DBMET00565 0.115 0.098 DBMET00573 0.491 0.004 DBMET00587 0.228 0.033 DBMET00614 | DBMET00587 | |
| 0.28 | 0.013 | 0.444 | Chelator | 0.404 0.005 DBMET00534 0.126 0.048 DBMET00587 0.444 0.005 DBMET00614 | DBMET00614 | |
| 0.268 | 0.005 | 0.268 | Creatine kinase inhibitor | 0.261 0.005 DBMET00534 0.157 0.021 DBMET00565 0.157 0.021 DBMET00573 0.175 0.016 DBMET00614 | ||
| 0.329 | 0.067 | 0.551 | Apoptosis antagonist | 0.422 0.033 DBMET00534 0.551 0.014 DBMET00587 0.275 0.104 DBMET00614 | DBMET00587 | |
| 0.322 | 0.061 | 0.393 | Lipoxygenase inhibitor | 0.393 0.039 DBMET00534 0.25 0.1 DBMET00614 | DBMET00534 | |
| 0.331 | 0.07 | 0.583 | Immunostimulant | 0.321 0.073 DBMET00534 0.406 0.048 DBMET00565 0.406 0.048 DBMET00573 0.583 0.019 DBMET00587 0.288 0.082 DBMET00614 | DBMET00587 | |
| 0.264 | 0.003 | 0.295 | DOPA decarboxylase inhibitor | 0.295 0.003 DBMET00534 0.135 0.031 DBMET00565 0.135 0.031 DBMET00573 0.104 0.069 DBMET00587 0.202 0.006 DBMET00614 | DBMET00534 | |
| 0.273 | 0.016 | 0.273 | Succinate dehydrogenase inhibitor | 0.271 0.016 DBMET00534 0.188 0.059 DBMET00565 0.188 0.059 DBMET00573 0.228 0.031 DBMET00614 | ||
| 0.277 | 0.021 | 0.649 | Monophenol monooxygenase inhibitor | 0.35 0.014 DBMET00534 0.199 0.033 DBMET00565 0.199 0.033 DBMET00573 0.649 0.004 DBMET00587 0.21 0.031 DBMET00614 | DBMET00587 | |
| 0.258 | 0.004 | 0.399 | Myeloperoxidase inhibitor | 0.399 0.003 DBMET00534 0.18 0.007 DBMET00614 | DBMET00534 | |
| 0.275 | 0.023 | 0.319 | MAO inhibitor | 0.29 0.021 DBMET00534 0.319 0.018 DBMET00614 | DBMET00614 | |
| 0.255 | 0.006 | 0.276 | GABA C receptor antagonist | 0.276 0.005 DBMET00534 0.174 0.019 DBMET00565 0.174 0.019 DBMET00573 0.222 0.009 DBMET00614 | DBMET00534 | |
| 0.258 | 0.009 | 0.324 | NMDA receptor antagonist | 0.24 0.01 DBMET00534 0.324 0.005 DBMET00565 0.324 0.005 DBMET00573 0.147 0.025 DBMET00614 | DBMET00573 | |
| 0.301 | 0.052 | 0.671 | Hypoglycemic | 0.314 0.048 DBMET00534 0.671 0.005 DBMET00587 0.208 0.105 DBMET00614 | DBMET00587 | |
| 0.297 | 0.05 | 0.779 | Angiogenesis stimulant | 0.306 0.047 DBMET00534 0.564 0.008 DBMET00565 0.564 0.008 DBMET00573 0.779 0.004 DBMET00587 0.182 0.104 DBMET00614 | DBMET00587 | |
| 0.299 | 0.052 | 0.448 | Antiamyloidogenic | 0.334 0.043 DBMET00534 0.448 0.022 DBMET00587 0.224 0.084 DBMET00614 | DBMET00587 | |
| 0.251 | 0.005 | 0.251 | HIV-1 integrase (Overall Integration) inhibitor | 0.237 0.006 DBMET00534 0.175 0.018 DBMET00565 0.175 0.018 DBMET00573 0.181 0.016 DBMET00614 | ||
| 0.299 | 0.054 | 0.308 | Transcription factor STAT3 inhibitor | 0.308 0.049 DBMET00534 0.302 0.052 DBMET00614 | DBMET00534 | |
| 0.268 | 0.025 | 0.268 | Insulin sensitizer | 0.258 0.03 DBMET00534 0.175 0.101 DBMET00565 0.175 0.101 DBMET00573 0.241 0.04 DBMET00587 0.258 0.03 DBMET00614 | ||
| 0.29 | 0.05 | 0.29 | Interleukin antagonist | 0.286 0.051 DBMET00534 0.145 0.121 DBMET00587 0.164 0.108 DBMET00614 | ||
| 0.249 | 0.009 | 0.249 | Toll-Like receptor 2 antagonist | 0.205 0.021 DBMET00534 0.14 0.06 DBMET00587 0.226 0.014 DBMET00614 | ||
| 0.242 | 0.006 | 0.258 | 5 Hydroxytryptamine 3A agonist | 0.227 0.009 DBMET00534 0.258 0.005 DBMET00614 | DBMET00614 | |
| 0.239 | 0.004 | 0.332 | Carbonic anhydrase VB inhibitor | 0.177 0.006 DBMET00534 0.332 0.003 DBMET00565 0.332 0.003 DBMET00573 0.169 0.007 DBMET00614 | DBMET00573 | |
| 0.32 | 0.087 | 0.342 | Vasodilator, peripheral | 0.325 0.085 DBMET00534 0.342 0.077 DBMET00587 0.23 0.144 DBMET00614 | DBMET00587 | |
| 0.235 | 0.005 | 0.235 | Adrenaline agonist | 0.221 0.005 DBMET00534 0.087 0.049 DBMET00565 0.087 0.049 DBMET00573 0.122 0.024 DBMET00614 | ||
| 0.235 | 0.005 | 0.238 | Prolactin inhibitor | 0.238 0.005 DBMET00534 0.084 0.075 DBMET00565 0.084 0.075 DBMET00573 0.164 0.017 DBMET00614 | DBMET00534 | |
| 0.25 | 0.022 | 0.591 | Hemostatic | 0.206 0.03 DBMET00534 0.591 0.004 DBMET00565 0.591 0.004 DBMET00573 0.564 0.004 DBMET00587 0.183 0.04 DBMET00614 | DBMET00573 | |
| 0.266 | 0.04 | 0.477 | DNA methylase inhibitor | 0.247 0.05 DBMET00534 0.477 0.006 DBMET00587 0.238 0.055 DBMET00614 | DBMET00587 | |
| 0.228 | 0.007 | 0.228 | Vanilloid 1 agonist | 0.187 0.016 DBMET00534 0.192 0.014 DBMET00565 0.192 0.014 DBMET00573 0.211 0.009 DBMET00587 0.177 0.02 DBMET00614 | ||
| 0.227 | 0.006 | 0.227 | Nitric-oxide synthase inhibitor | 0.216 0.007 DBMET00534 0.159 0.019 DBMET00565 0.159 0.019 DBMET00573 0.225 0.006 DBMET00614 | ||
| 0.242 | 0.022 | 0.242 | Neurotensin receptor agonist | 0.213 0.029 DBMET00534 0.152 0.097 DBMET00565 0.152 0.097 DBMET00573 0.208 0.031 DBMET00614 | ||
| 0.225 | 0.006 | 0.231 | Inducible nitric-oxide synthase inhibitor | 0.225 0.006 DBMET00534 0.182 0.01 DBMET00565 0.182 0.01 DBMET00573 0.231 0.006 DBMET00614 | DBMET00614 | |
| 0.223 | 0.005 | 0.682 | Carbonic anhydrase V inhibitor | 0.203 0.007 DBMET00534 0.682 0.002 DBMET00565 0.682 0.002 DBMET00573 0.166 0.011 DBMET00614 | DBMET00573 | |
| 0.247 | 0.029 | 0.616 | Amylase inhibitor | 0.257 0.026 DBMET00534 0.616 0.004 DBMET00587 0.188 0.048 DBMET00614 | DBMET00587 | |
| 0.216 | 0.003 | 0.216 | GABA B receptor agonist | 0.194 0.004 DBMET00534 0.11 0.011 DBMET00565 0.11 0.011 DBMET00573 0.167 0.004 DBMET00614 | ||
| 0.216 | 0.005 | 0.216 | Histamine N-methyltransferase inhibitor | 0.18 0.007 DBMET00534 0.105 0.041 DBMET00565 0.105 0.041 DBMET00573 0.199 0.005 DBMET00614 | ||
| 0.277 | 0.066 | 0.277 | Cardiotonic | 0.193 0.125 DBMET00534 0.176 0.143 DBMET00587 0.214 0.107 DBMET00614 | ||
| 0.238 | 0.028 | 0.238 | Acetylcholine M1 receptor antagonist | 0.182 0.051 DBMET00534 0.192 0.046 DBMET00614 | ||
| 0.294 | 0.085 | 0.294 | Sodium/bile acid cotransporter inhibitor | 0.252 0.126 DBMET00534 0.28 0.098 DBMET00565 0.28 0.098 DBMET00573 0.204 0.183 DBMET00587 | ||
| 0.227 | 0.02 | 0.227 | Death-associated protein kinase 2 inhibitor | 0.198 0.036 DBMET00534 0.179 0.055 DBMET00614 | ||
| 0.213 | 0.009 | 0.213 | Dopamine agonist | 0.166 0.013 DBMET00534 0.203 0.01 DBMET00565 0.203 0.01 DBMET00573 0.063 0.049 DBMET00614 | ||
| 0.23 | 0.026 | 0.327 | Alpha-N-acetylglucosaminidase inhibitor | 0.204 0.033 DBMET00534 0.327 0.014 DBMET00587 0.189 0.038 DBMET00614 | DBMET00587 | |
| 0.236 | 0.035 | 0.236 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.221 0.04 DBMET00534 0.231 0.037 DBMET00614 | ||
| 0.214 | 0.014 | 0.551 | Cyclooxygenase 3 inhibitor | 0.172 0.032 DBMET00534 0.551 0.003 DBMET00587 0.191 0.022 DBMET00614 | DBMET00587 | |
| 0.214 | 0.018 | 0.249 | Aminopeptidase B inhibitor | 0.174 0.029 DBMET00534 0.249 0.013 DBMET00565 0.249 0.013 DBMET00573 0.194 0.023 DBMET00614 | DBMET00573 | |
| 0.227 | 0.031 | 0.227 | Phospholipase A2 inhibitor | 0.219 0.034 DBMET00534 0.179 0.054 DBMET00565 0.179 0.054 DBMET00573 0.19 0.048 DBMET00587 0.202 0.041 DBMET00614 | ||
| 0.227 | 0.032 | 0.367 | Lipid peroxidase inhibitor | 0.317 0.017 DBMET00534 0.206 0.039 DBMET00565 0.206 0.039 DBMET00573 0.367 0.011 DBMET00587 | DBMET00587 | |
| 0.213 | 0.02 | 0.23 | Ferrochelatase inhibitor | 0.189 0.025 DBMET00534 0.23 0.016 DBMET00614 | DBMET00614 | |
| 0.216 | 0.024 | 0.226 | DNA polymerase I inhibitor | 0.216 0.024 DBMET00534 0.128 0.063 DBMET00565 0.128 0.063 DBMET00573 0.214 0.024 DBMET00587 0.226 0.021 DBMET00614 | DBMET00614 | |
| 0.214 | 0.022 | 0.265 | MAO B inhibitor | 0.196 0.025 DBMET00534 0.265 0.016 DBMET00614 | DBMET00614 | |
| 0.244 | 0.053 | 0.345 | RNA-directed DNA polymerase inhibitor | 0.277 0.037 DBMET00534 0.345 0.025 DBMET00565 0.345 0.025 DBMET00573 0.21 0.086 DBMET00587 0.235 0.059 DBMET00614 | DBMET00573 | |
| 0.198 | 0.008 | 0.216 | GABA C receptor rho-1 antagonist | 0.216 0.006 DBMET00534 0.201 0.008 DBMET00614 | DBMET00534 | |
| 0.196 | 0.008 | 0.24 | CYP2A6 inhibitor | 0.146 0.017 DBMET00534 0.24 0.005 DBMET00614 | DBMET00614 | |
| 0.192 | 0.005 | 0.503 | Carbonic anhydrase VA inhibitor | 0.179 0.006 DBMET00534 0.503 0.002 DBMET00565 0.503 0.002 DBMET00573 0.152 0.01 DBMET00614 | DBMET00573 | |
| 0.196 | 0.01 | 0.354 | NMDA 2 receptor antagonist | 0.157 0.015 DBMET00534 0.354 0.004 DBMET00565 0.354 0.004 DBMET00573 0.11 0.027 DBMET00614 | DBMET00573 | |
| 0.189 | 0.004 | 0.317 | 5 Hydroxytryptamine 1B agonist | 0.126 0.005 DBMET00534 0.066 0.021 DBMET00565 0.066 0.021 DBMET00573 0.317 0.004 DBMET00614 | DBMET00614 | |
| 0.189 | 0.011 | 0.189 | Sphingosine 1-phosphate receptor 2 antagonist | 0.169 0.022 DBMET00534 0.168 0.022 DBMET00614 | ||
| 0.204 | 0.027 | 0.204 | Aldehyde dehydrogenase inhibitor | 0.143 0.052 DBMET00534 0.196 0.029 DBMET00587 0.189 0.03 DBMET00614 | ||
| 0.186 | 0.009 | 0.196 | Heat shock protein 70 antagonist | 0.18 0.012 DBMET00534 0.196 0.007 DBMET00587 0.179 0.012 DBMET00614 | DBMET00587 | |
| 0.237 | 0.061 | 0.237 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.21 0.071 DBMET00534 0.184 0.085 DBMET00614 | ||
| 0.329 | 0.153 | 0.593 | Apoptosis agonist | 0.486 0.079 DBMET00534 0.593 0.051 DBMET00587 0.266 0.198 DBMET00614 | DBMET00587 | |
| 0.204 | 0.028 | 0.39 | Cell wall synthesis inhibitor | 0.19 0.034 DBMET00534 0.39 0.006 DBMET00565 0.39 0.006 DBMET00573 0.383 0.007 DBMET00587 0.194 0.032 DBMET00614 | DBMET00573 | |
| 0.183 | 0.008 | 0.183 | Vanilloid agonist | 0.129 0.015 DBMET00534 0.128 0.015 DBMET00565 0.128 0.015 DBMET00573 0.099 0.034 DBMET00587 0.098 0.035 DBMET00614 | ||
| 0.217 | 0.044 | 0.217 | Tumour necrosis factor antagonist | 0.168 0.078 DBMET00534 0.197 0.055 DBMET00614 | ||
| 0.186 | 0.013 | 0.195 | Sphingomyelinase inhibitor | 0.166 0.018 DBMET00534 0.162 0.02 DBMET00587 0.195 0.011 DBMET00614 | DBMET00614 | |
| 0.187 | 0.014 | 0.187 | TRPA1 agonist | 0.156 0.027 DBMET00534 0.172 0.019 DBMET00565 0.172 0.019 DBMET00573 0.134 0.044 DBMET00587 0.158 0.026 DBMET00614 | ||
| 0.181 | 0.01 | 0.181 | Macrophage migration inhibitory factor inhibitor | 0.158 0.013 DBMET00534 0.131 0.021 DBMET00614 | ||
| 0.201 | 0.03 | 0.218 | Histone deacetylase SIRT1 inhibitor | 0.218 0.024 DBMET00534 0.182 0.039 DBMET00614 | DBMET00534 | |
| 0.188 | 0.018 | 0.188 | Sphingosine 1-phosphate receptor 5 antagonist | 0.176 0.027 DBMET00534 0.169 0.035 DBMET00614 | ||
| 0.174 | 0.004 | 0.199 | 5 Hydroxytryptamine 2A agonist | 0.199 0.004 DBMET00534 0.166 0.005 DBMET00614 | DBMET00534 | |
| 0.18 | 0.01 | 0.181 | Transcription factor STAT6 inhibitor | 0.181 0.01 DBMET00534 0.156 0.019 DBMET00614 | DBMET00534 | |
| 0.184 | 0.016 | 0.238 | 5 Hydroxytryptamine agonist | 0.168 0.018 DBMET00534 0.238 0.011 DBMET00614 | DBMET00614 | |
| 0.185 | 0.017 | 0.226 | Mucolytic | 0.179 0.019 DBMET00534 0.103 0.074 DBMET00565 0.103 0.074 DBMET00573 0.226 0.009 DBMET00587 0.14 0.039 DBMET00614 | DBMET00587 | |
| 0.26 | 0.092 | 0.289 | Hypoxia-inducible factor 1 alpha inhibitor | 0.289 0.071 DBMET00534 0.282 0.075 DBMET00587 0.213 0.137 DBMET00614 | DBMET00534 | |
| 0.168 | 0.003 | 0.168 | Dopamine beta hydroxylase inhibitor | 0.106 0.004 DBMET00534 0.053 0.025 DBMET00565 0.053 0.025 DBMET00573 0.143 0.003 DBMET00614 | ||
| 0.175 | 0.011 | 0.178 | Keratolytic | 0.178 0.01 DBMET00534 0.106 0.027 DBMET00614 | DBMET00534 | |
| 0.198 | 0.035 | 0.198 | Arachidonic acid antagonist | 0.187 0.046 DBMET00534 0.185 0.048 DBMET00614 | ||
| 0.166 | 0.003 | 0.166 | Estrogen-related receptor beta agonist | 0.123 0.009 DBMET00534 0.09 0.04 DBMET00565 0.09 0.04 DBMET00573 0.081 0.063 DBMET00587 0.132 0.006 DBMET00614 | ||
| 0.169 | 0.007 | 0.169 | Ornithine decarboxylase inhibitor | 0.162 0.008 DBMET00534 0.081 0.066 DBMET00565 0.081 0.066 DBMET00573 0.13 0.019 DBMET00587 0.159 0.009 DBMET00614 | ||
| 0.233 | 0.073 | 0.233 | Neuropeptide Y2 antagonist | 0.194 0.13 DBMET00534 0.23 0.077 DBMET00614 | ||
| 0.236 | 0.079 | 0.238 | Calpain inhibitor | 0.184 0.129 DBMET00534 0.238 0.076 DBMET00614 | DBMET00614 | |
| 0.204 | 0.05 | 0.399 | Thrombolytic | 0.207 0.049 DBMET00534 0.275 0.028 DBMET00565 0.275 0.028 DBMET00573 0.399 0.011 DBMET00587 0.145 0.085 DBMET00614 | DBMET00587 | |
| 0.183 | 0.034 | 0.192 | CF transmembrane conductance regulator agonist | 0.192 0.027 DBMET00534 0.173 0.043 DBMET00614 | DBMET00534 | |
| 0.157 | 0.009 | 0.157 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.033 DBMET00534 0.146 0.013 DBMET00614 | ||
| 0.155 | 0.007 | 0.155 | NMDA 2A receptor antagonist | 0.155 0.007 DBMET00534 0.104 0.012 DBMET00565 0.104 0.012 DBMET00573 0.11 0.011 DBMET00614 | ||
| 0.17 | 0.023 | 0.182 | Interleukin 8 antagonist | 0.182 0.018 DBMET00534 0.124 0.056 DBMET00614 | DBMET00534 | |
| 0.173 | 0.027 | 0.558 | Expectorant | 0.161 0.031 DBMET00534 0.558 0.003 DBMET00587 0.109 0.059 DBMET00614 | DBMET00587 | |
| 0.228 | 0.084 | 0.379 | DNA synthesis inhibitor | 0.219 0.095 DBMET00534 0.379 0.025 DBMET00587 0.219 0.096 DBMET00614 | DBMET00587 | |
| 0.181 | 0.037 | 0.205 | Neurotrophic factor | 0.205 0.025 DBMET00534 0.138 0.071 DBMET00587 0.13 0.08 DBMET00614 | DBMET00534 | |
| 0.175 | 0.032 | 0.246 | Interleukin 4 antagonist | 0.246 0.014 DBMET00534 0.17 0.035 DBMET00587 | DBMET00534 | |
| 0.207 | 0.066 | 0.385 | DNA methyltransferase I inhibitor | 0.198 0.07 DBMET00534 0.385 0.01 DBMET00587 0.17 0.086 DBMET00614 | DBMET00587 | |
| 0.155 | 0.015 | 0.155 | Glutamate dehydrogenase inhibitor | 0.139 0.018 DBMET00534 0.083 0.042 DBMET00565 0.083 0.042 DBMET00573 0.094 0.034 DBMET00587 0.132 0.019 DBMET00614 | ||
| 0.145 | 0.006 | 0.145 | Beta adrenoreceptor antagonist | 0.136 0.007 DBMET00534 0.066 0.045 DBMET00565 0.066 0.045 DBMET00573 0.099 0.017 DBMET00614 | ||
| 0.248 | 0.109 | 0.248 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.22 0.135 DBMET00534 | ||
| 0.165 | 0.027 | 0.171 | Bronchodilator | 0.171 0.024 DBMET00534 0.117 0.047 DBMET00587 0.127 0.041 DBMET00614 | DBMET00534 | |
| 0.166 | 0.029 | 0.166 | Falcipain 3 inhibitor | 0.157 0.033 DBMET00534 0.131 0.046 DBMET00614 | ||
| 0.269 | 0.135 | 0.509 | Immunosuppressant | 0.246 0.151 DBMET00534 0.509 0.03 DBMET00587 0.291 0.121 DBMET00614 | DBMET00587 | |
| 0.198 | 0.066 | 0.497 | Hepatoprotectant | 0.229 0.05 DBMET00534 0.248 0.044 DBMET00565 0.248 0.044 DBMET00573 0.497 0.007 DBMET00587 | DBMET00587 | |
| 0.319 | 0.188 | 0.373 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.27 0.256 DBMET00534 0.373 0.126 DBMET00614 | DBMET00614 | |
| 0.198 | 0.068 | 0.461 | Nitric oxide antagonist | 0.28 0.044 DBMET00534 0.153 0.092 DBMET00565 0.153 0.092 DBMET00573 0.461 0.019 DBMET00587 0.134 0.113 DBMET00614 | DBMET00587 | |
| 0.201 | 0.07 | 0.485 | Non-steroidal antiinflammatory agent | 0.198 0.072 DBMET00534 0.485 0.007 DBMET00587 0.205 0.067 DBMET00614 | DBMET00587 | |
| 0.154 | 0.025 | 0.154 | Adenylate kinase inhibitor | 0.148 0.027 DBMET00534 0.097 0.072 DBMET00565 0.097 0.072 DBMET00573 0.105 0.059 DBMET00587 0.145 0.028 DBMET00614 | ||
| 0.135 | 0.006 | 0.135 | Beta 1 adrenoreceptor antagonist | 0.115 0.008 DBMET00534 0.052 0.044 DBMET00565 0.052 0.044 DBMET00573 0.09 0.013 DBMET00614 | ||
| 0.199 | 0.07 | 0.199 | Histone acetyltransferase inhibitor | 0.176 0.105 DBMET00534 0.187 0.09 DBMET00614 | ||
| 0.154 | 0.025 | 0.177 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.105 0.05 DBMET00534 0.177 0.02 DBMET00587 0.142 0.029 DBMET00614 | DBMET00587 | |
| 0.156 | 0.028 | 0.159 | Protein kinase C gamma inhibitor | 0.159 0.027 DBMET00534 0.113 0.059 DBMET00614 | DBMET00534 | |
| 0.133 | 0.005 | 0.297 | Carbonic anhydrase XIV inhibitor | 0.157 0.005 DBMET00534 0.104 0.01 DBMET00565 0.104 0.01 DBMET00573 0.297 0.004 DBMET00587 0.084 0.015 DBMET00614 | DBMET00587 | |
| 0.141 | 0.014 | 0.141 | Aminopeptidase I inhibitor | 0.11 0.023 DBMET00534 0.128 0.017 DBMET00614 | ||
| 0.154 | 0.029 | 0.21 | Photosensitizer | 0.173 0.02 DBMET00534 0.21 0.011 DBMET00587 0.152 0.03 DBMET00614 | DBMET00587 | |
| 0.147 | 0.021 | 0.147 | Alcohol dehydrogenase inhibitor | 0.131 0.028 DBMET00534 0.131 0.028 DBMET00587 0.101 0.052 DBMET00614 | ||
| 0.137 | 0.012 | 0.137 | Carbonic anhydrase stimulant | 0.103 0.018 DBMET00534 0.055 0.047 DBMET00565 0.055 0.047 DBMET00573 0.115 0.015 DBMET00614 | ||
| 0.177 | 0.052 | 0.356 | Interferon gamma antagonist | 0.171 0.056 DBMET00534 0.356 0.014 DBMET00587 0.151 0.077 DBMET00614 | DBMET00587 | |
| 0.152 | 0.028 | 0.324 | UDP-glucose 4-epimerase inhibitor | 0.149 0.029 DBMET00534 0.324 0.009 DBMET00587 0.138 0.033 DBMET00614 | DBMET00587 | |
| 0.129 | 0.004 | 0.129 | Sphingosine kinase 2 inhibitor | 0.116 0.005 DBMET00534 0.081 0.015 DBMET00614 | ||
| 0.163 | 0.039 | 0.222 | Cholesterol synthesis inhibitor | 0.145 0.047 DBMET00534 0.222 0.022 DBMET00565 0.222 0.022 DBMET00573 0.113 0.072 DBMET00587 0.116 0.069 DBMET00614 | DBMET00573 | |
| 0.132 | 0.008 | 0.132 | Beta 3 adrenoreceptor antagonist | 0.103 0.014 DBMET00534 0.069 0.035 DBMET00565 0.069 0.035 DBMET00573 0.076 0.026 DBMET00614 | ||
| 0.127 | 0.004 | 0.138 | Diamine oxidase inhibitor | 0.105 0.004 DBMET00534 0.138 0.003 DBMET00614 | DBMET00614 | |
| 0.172 | 0.049 | 0.185 | GABA C receptor rho-2 antagonist | 0.185 0.038 DBMET00534 0.182 0.04 DBMET00614 | DBMET00534 | |
| 0.142 | 0.02 | 0.238 | NADH dehydrogenase inhibitor | 0.124 0.026 DBMET00534 0.088 0.059 DBMET00565 0.088 0.059 DBMET00573 0.238 0.008 DBMET00587 0.124 0.026 DBMET00614 | DBMET00587 | |
| 0.155 | 0.033 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.149 0.044 DBMET00534 0.146 0.052 DBMET00587 0.147 0.05 DBMET00614 | ||
| 0.165 | 0.046 | 0.165 | Toll-Like receptor antagonist | 0.113 0.096 DBMET00534 0.164 0.047 DBMET00614 | ||
| 0.142 | 0.023 | 0.314 | Triose-phosphate isomerase inhibitor | 0.116 0.034 DBMET00534 0.314 0.004 DBMET00565 0.314 0.004 DBMET00573 0.235 0.008 DBMET00587 0.152 0.019 DBMET00614 | DBMET00573 | |
| 0.127 | 0.009 | 0.13 | NMDA 2C receptor antagonist | 0.091 0.019 DBMET00534 0.13 0.009 DBMET00565 0.13 0.009 DBMET00573 0.103 0.015 DBMET00614 | DBMET00573 | |
| 0.144 | 0.026 | 0.144 | Urease inhibitor | 0.139 0.029 DBMET00534 0.112 0.054 DBMET00614 | ||
| 0.174 | 0.058 | 0.498 | Diuretic | 0.183 0.052 DBMET00534 0.498 0.008 DBMET00565 0.498 0.008 DBMET00573 0.343 0.017 DBMET00587 0.151 0.077 DBMET00614 | DBMET00573 | |
| 0.128 | 0.011 | 0.154 | NMDA receptor agonist | 0.098 0.02 DBMET00534 0.154 0.008 DBMET00565 0.154 0.008 DBMET00573 0.124 0.012 DBMET00614 | DBMET00573 | |
| 0.17 | 0.054 | 0.201 | Thiol protease inhibitor | 0.138 0.083 DBMET00534 0.201 0.039 DBMET00614 | DBMET00614 | |
| 0.156 | 0.04 | 0.156 | Acetylcholine muscarinic antagonist | 0.135 0.054 DBMET00534 0.124 0.063 DBMET00614 | ||
| 0.126 | 0.011 | 0.132 | Glycine receptor agonist | 0.132 0.01 DBMET00534 0.069 0.056 DBMET00565 0.069 0.056 DBMET00573 0.104 0.019 DBMET00587 0.094 0.025 DBMET00614 | DBMET00534 | |
| 0.133 | 0.019 | 0.133 | Somatostatin 1 agonist | 0.106 0.03 DBMET00534 0.071 0.063 DBMET00565 0.071 0.063 DBMET00573 0.069 0.066 DBMET00587 0.118 0.024 DBMET00614 | ||
| 0.134 | 0.021 | 0.226 | Phosphofructokinase-1 inhibitor | 0.137 0.021 DBMET00534 0.062 0.054 DBMET00565 0.062 0.054 DBMET00573 0.226 0.009 DBMET00587 0.11 0.028 DBMET00614 | DBMET00587 | |
| 0.135 | 0.024 | 0.141 | Aminoacyl-tRNA synthetase inhibitor | 0.141 0.022 DBMET00534 0.09 0.058 DBMET00565 0.09 0.058 DBMET00573 0.094 0.052 DBMET00587 0.115 0.033 DBMET00614 | DBMET00534 | |
| 0.128 | 0.017 | 0.142 | Histamine H2 receptor antagonist | 0.109 0.027 DBMET00534 0.142 0.012 DBMET00614 | DBMET00614 | |
| 0.128 | 0.016 | 0.196 | 5 Hydroxytryptamine 1 agonist | 0.07 0.028 DBMET00534 0.196 0.011 DBMET00614 | DBMET00614 | |
| 0.122 | 0.011 | 0.122 | 5 Hydroxytryptamine 5A antagonist | 0.065 0.037 DBMET00534 0.105 0.014 DBMET00614 | ||
| 0.235 | 0.126 | 0.369 | Caspase 3 stimulant | 0.369 0.053 DBMET00534 0.305 0.076 DBMET00587 0.239 0.122 DBMET00614 | DBMET00534 | |
| 0.21 | 0.101 | 0.573 | Tumour necrosis factor alpha release inhibitor | 0.176 0.129 DBMET00534 0.573 0.009 DBMET00587 | DBMET00587 | |
| 0.129 | 0.02 | 0.129 | Alpha adrenoreceptor agonist | 0.1 0.028 DBMET00534 0.067 0.048 DBMET00614 | ||
| 0.138 | 0.03 | 0.138 | Opioid antagonist | 0.095 0.052 DBMET00534 0.094 0.052 DBMET00614 | ||
| 0.112 | 0.004 | 0.112 | Beta 2 adrenoreceptor agonist | 0.111 0.004 DBMET00534 0.077 0.011 DBMET00565 0.077 0.011 DBMET00573 0.077 0.011 DBMET00614 | ||
| 0.15 | 0.043 | 0.151 | Histone deacetylase class III inhibitor | 0.151 0.043 DBMET00534 0.136 0.056 DBMET00614 | DBMET00534 | |
| 0.151 | 0.045 | 0.165 | Cathepsin H inhibitor | 0.107 0.095 DBMET00534 0.165 0.036 DBMET00614 | DBMET00614 | |
| 0.112 | 0.006 | 0.112 | Kinesin-like protein 1 inhibitor | 0.081 0.01 DBMET00534 0.065 0.013 DBMET00565 0.065 0.013 DBMET00573 0.109 0.007 DBMET00614 | ||
| 0.112 | 0.006 | 0.112 | Kinesin antagonist | 0.081 0.01 DBMET00534 0.065 0.013 DBMET00565 0.065 0.013 DBMET00573 0.109 0.007 DBMET00614 | ||
| 0.153 | 0.048 | 0.153 | Anesthetic local | 0.152 0.048 DBMET00534 0.121 0.066 DBMET00614 | ||
| 0.112 | 0.007 | 0.112 | Beta 2 adrenoreceptor antagonist | 0.101 0.008 DBMET00534 0.05 0.037 DBMET00565 0.05 0.037 DBMET00573 0.069 0.017 DBMET00614 | ||
| 0.144 | 0.04 | 0.227 | 5-Lipoxygenase inhibitor | 0.227 0.019 DBMET00534 0.084 0.077 DBMET00614 | DBMET00534 | |
| 0.133 | 0.029 | 0.15 | Anabolic | 0.134 0.028 DBMET00534 0.15 0.018 DBMET00565 0.15 0.018 DBMET00573 0.141 0.023 DBMET00614 | DBMET00573 | |
| 0.199 | 0.095 | 0.417 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 DBMET00534 0.417 0.014 DBMET00587 0.152 0.149 DBMET00614 | DBMET00587 | |
| 0.158 | 0.054 | 0.222 | Alkaline phosphatase inhibitor | 0.138 0.068 DBMET00534 0.222 0.026 DBMET00565 0.222 0.026 DBMET00573 0.172 0.047 DBMET00587 0.107 0.105 DBMET00614 | DBMET00573 | |
| 0.109 | 0.006 | 0.133 | Sphingosine kinase inhibitor | 0.105 0.006 DBMET00534 0.133 0.004 DBMET00565 0.133 0.004 DBMET00573 0.075 0.02 DBMET00614 | DBMET00573 | |
| 0.119 | 0.016 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.03 DBMET00534 0.096 0.041 DBMET00614 | ||
| 0.112 | 0.009 | 0.288 | Dopamine D2 agonist | 0.085 0.013 DBMET00534 0.288 0.004 DBMET00565 0.288 0.004 DBMET00573 0.06 0.021 DBMET00587 | DBMET00573 | |
| 0.156 | 0.054 | 0.156 | Nav1.2 sodium channel blocker | 0.136 0.067 DBMET00565 0.136 0.067 DBMET00573 0.155 0.054 DBMET00614 | ||
| 0.115 | 0.012 | 0.115 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.042 DBMET00534 0.098 0.015 DBMET00614 | ||
| 0.106 | 0.005 | 0.106 | Vanilloid 2 antagonist | 0.088 0.007 DBMET00534 0.084 0.008 DBMET00565 0.084 0.008 DBMET00573 0.066 0.017 DBMET00614 | ||
| 0.109 | 0.007 | 0.109 | MAP kinase kinase 7 inhibitor | 0.098 0.015 DBMET00534 0.095 0.018 DBMET00614 | ||
| 0.143 | 0.043 | 0.163 | MAO A inhibitor | 0.163 0.038 DBMET00534 0.102 0.063 DBMET00614 | DBMET00534 | |
| 0.116 | 0.016 | 0.123 | D-Ala-D-Ala ligase inhibitor | 0.123 0.012 DBMET00534 0.089 0.047 DBMET00614 | DBMET00534 | |
| 0.133 | 0.035 | 0.148 | Estrogen antagonist | 0.148 0.024 DBMET00534 | DBMET00534 | |
| 0.157 | 0.059 | 0.157 | Mannose-6-phosphate isomerase inhibitor | 0.15 0.064 DBMET00534 0.154 0.061 DBMET00587 0.155 0.061 DBMET00614 | ||
| 0.123 | 0.025 | 0.123 | Opioid delta receptor antagonist | 0.066 0.043 DBMET00534 0.062 0.045 DBMET00614 | ||
| 0.111 | 0.013 | 0.122 | Maillard reaction inhibitor | 0.122 0.01 DBMET00534 0.064 0.032 DBMET00587 0.055 0.039 DBMET00614 | DBMET00534 | |
| 0.198 | 0.101 | 0.295 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.295 0.066 DBMET00534 0.184 0.11 DBMET00614 | DBMET00534 | |
| 0.13 | 0.035 | 0.181 | Toll-Like receptor 4 antagonist | 0.107 0.058 DBMET00534 0.181 0.009 DBMET00587 0.096 0.077 DBMET00614 | DBMET00587 | |
| 0.148 | 0.053 | 0.148 | Cholinergic antagonist | 0.121 0.073 DBMET00534 0.121 0.072 DBMET00614 | ||
| 0.114 | 0.021 | 0.407 | HIV-1 integrase (3'-Processing) inhibitor | 0.135 0.016 DBMET00534 0.407 0.004 DBMET00565 0.407 0.004 DBMET00573 0.078 0.035 DBMET00587 | DBMET00573 | |
| 0.145 | 0.053 | 0.145 | Acetylcholine antagonist | 0.118 0.072 DBMET00534 0.119 0.071 DBMET00614 | ||
| 0.137 | 0.045 | 0.137 | Alpha 2b adrenoreceptor antagonist | 0.108 0.068 DBMET00534 0.102 0.073 DBMET00614 | ||
| 0.099 | 0.007 | 0.099 | Epithelial sodium channel blocker | 0.084 0.011 DBMET00534 0.094 0.008 DBMET00614 | ||
| 0.096 | 0.005 | 0.102 | Adenylate cyclase 1 inhibitor | 0.068 0.013 DBMET00534 0.102 0.004 DBMET00614 | DBMET00614 | |
| 0.126 | 0.035 | 0.126 | Alpha 2 adrenoreceptor antagonist | 0.091 0.055 DBMET00534 0.077 0.07 DBMET00614 | ||
| 0.143 | 0.053 | 0.171 | Antibacterial (Helicobacter pylori) | 0.171 0.032 DBMET00534 0.113 0.093 DBMET00565 0.113 0.093 DBMET00573 0.122 0.078 DBMET00614 | DBMET00534 | |
| 0.111 | 0.022 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.116 0.018 DBMET00534 0.117 0.018 DBMET00565 0.117 0.018 DBMET00573 0.13 0.011 DBMET00587 0.108 0.025 DBMET00614 | DBMET00587 | |
| 0.158 | 0.07 | 0.256 | Hexokinase inhibitor | 0.177 0.051 DBMET00534 0.256 0.016 DBMET00587 0.18 0.049 DBMET00614 | DBMET00587 | |
| 0.117 | 0.03 | 0.125 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.125 0.027 DBMET00534 0.08 0.051 DBMET00614 | DBMET00534 | |
| 0.182 | 0.095 | 0.232 | Antimitotic | 0.18 0.096 DBMET00534 0.232 0.067 DBMET00565 0.232 0.067 DBMET00573 0.192 0.089 DBMET00614 | DBMET00573 | |
| 0.135 | 0.049 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | 0.144 0.039 DBMET00614 | DBMET00614 | |
| 0.134 | 0.048 | 0.27 | Topoisomerase I inhibitor | 0.157 0.039 DBMET00534 0.087 0.083 DBMET00565 0.087 0.083 DBMET00573 0.27 0.014 DBMET00587 0.099 0.071 DBMET00614 | DBMET00587 | |
| 0.1 | 0.014 | 0.104 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.089 0.023 DBMET00534 0.104 0.011 DBMET00614 | DBMET00614 | |
| 0.13 | 0.044 | 0.18 | Nav1.4 sodium channel blocker | 0.096 0.083 DBMET00534 0.18 0.024 DBMET00565 0.18 0.024 DBMET00573 0.111 0.061 DBMET00614 | DBMET00573 | |
| 0.119 | 0.033 | 0.135 | Estrogen receptor beta antagonist | 0.135 0.02 DBMET00534 | DBMET00534 | |
| 0.113 | 0.027 | 0.113 | Opioid mu receptor antagonist | 0.067 0.048 DBMET00534 0.068 0.047 DBMET00614 | ||
| 0.1 | 0.017 | 0.1 | Purinergic P2X1 antagonist | 0.085 0.022 DBMET00534 0.072 0.031 DBMET00614 | ||
| 0.114 | 0.031 | 0.114 | Alpha 2a adrenoreceptor antagonist | 0.085 0.045 DBMET00534 | ||
| 0.09 | 0.008 | 0.096 | Phosphoglycerate kinase inhibitor | 0.089 0.008 DBMET00534 0.096 0.007 DBMET00565 0.096 0.007 DBMET00573 0.038 0.021 DBMET00587 0.049 0.014 DBMET00614 | DBMET00573 | |
| 0.19 | 0.109 | 0.38 | Platelet antagonist | 0.16 0.135 DBMET00534 0.213 0.092 DBMET00565 0.213 0.092 DBMET00573 0.38 0.031 DBMET00587 0.151 0.143 DBMET00614 | DBMET00587 | |
| 0.135 | 0.053 | 0.143 | Beta amyloid protein antagonist | 0.138 0.05 DBMET00534 0.143 0.045 DBMET00587 0.116 0.071 DBMET00614 | DBMET00587 | |
| 0.117 | 0.035 | 0.117 | Protein kinase A inhibitor | 0.115 0.036 DBMET00534 0.081 0.059 DBMET00614 | ||
| 0.1 | 0.019 | 0.1 | Biliverdin reductase inhibitor | 0.086 0.024 DBMET00534 0.089 0.022 DBMET00614 | ||
| 0.162 | 0.081 | 0.28 | ATPase inhibitor | 0.154 0.095 DBMET00534 0.28 0.008 DBMET00587 | DBMET00587 | |
| 0.111 | 0.03 | 0.124 | Bile acid receptor antagonist | 0.124 0.017 DBMET00534 0.115 0.025 DBMET00565 0.115 0.025 DBMET00573 0.089 0.075 DBMET00614 | DBMET00534 | |
| 0.152 | 0.072 | 0.301 | Insulin secretagoues | 0.301 0.012 DBMET00587 | DBMET00587 | |
| 0.096 | 0.016 | 0.096 | Alpha 2 adrenoreceptor agonist | 0.079 0.024 DBMET00534 0.063 0.039 DBMET00614 | ||
| 0.134 | 0.056 | 0.263 | Alkylator | 0.117 0.07 DBMET00534 0.109 0.079 DBMET00565 0.109 0.079 DBMET00573 0.263 0.015 DBMET00587 0.144 0.05 DBMET00614 | DBMET00587 | |
| 0.155 | 0.076 | 0.624 | Anticoagulant | 0.141 0.088 DBMET00534 0.624 0.005 DBMET00565 0.624 0.005 DBMET00573 0.319 0.025 DBMET00587 0.125 0.105 DBMET00614 | DBMET00573 | |
| 0.147 | 0.069 | 0.154 | Neuropeptide Y1 antagonist | 0.122 0.12 DBMET00534 0.154 0.059 DBMET00614 | DBMET00614 | |
| 0.103 | 0.025 | 0.117 | Estrogen receptor alpha antagonist | 0.117 0.02 DBMET00534 0.074 0.06 DBMET00614 | DBMET00534 | |
| 0.089 | 0.011 | 0.089 | Carbonic anhydrase VII inhibitor | 0.085 0.012 DBMET00534 0.042 0.038 DBMET00565 0.042 0.038 DBMET00573 0.057 0.021 DBMET00587 0.056 0.022 DBMET00614 | ||
| 0.095 | 0.018 | 0.099 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.099 0.017 DBMET00534 0.085 0.022 DBMET00587 0.057 0.042 DBMET00614 | DBMET00534 | |
| 0.098 | 0.021 | 0.098 | Carbamoyl phosphate synthetase inhibitor | 0.098 0.021 DBMET00534 0.083 0.027 DBMET00614 | ||
| 0.122 | 0.046 | 0.144 | Acetylcholine release stimulant | 0.101 0.086 DBMET00534 0.144 0.02 DBMET00565 0.144 0.02 DBMET00573 0.106 0.074 DBMET00587 0.141 0.023 DBMET00614 | DBMET00573 | |
| 0.087 | 0.013 | 0.098 | 5 Hydroxytryptamine 2 agonist | 0.098 0.01 DBMET00534 0.088 0.012 DBMET00614 | DBMET00534 | |
| 0.089 | 0.015 | 0.089 | Glycine transporter 2 inhibitor | 0.052 0.029 DBMET00534 0.063 0.024 DBMET00614 | ||
| 0.079 | 0.004 | 0.079 | Beta adrenoreceptor agonist | 0.074 0.005 DBMET00534 0.047 0.025 DBMET00565 0.047 0.025 DBMET00573 0.049 0.019 DBMET00614 | ||
| 0.094 | 0.02 | 0.094 | Acetylcholine M3 receptor antagonist | 0.077 0.027 DBMET00534 0.061 0.04 DBMET00614 | ||
| 0.093 | 0.019 | 0.096 | 5 Hydroxytryptamine 3 agonist | 0.08 0.027 DBMET00534 0.096 0.017 DBMET00614 | DBMET00614 | |
| 0.094 | 0.021 | 0.104 | Argininosuccinate synthase inhibitor | 0.085 0.023 DBMET00534 0.104 0.018 DBMET00614 | DBMET00614 | |
| 0.155 | 0.082 | 0.214 | Interleukin 6 antagonist | 0.202 0.04 DBMET00534 0.214 0.034 DBMET00587 | DBMET00587 | |
| 0.096 | 0.025 | 0.108 | Sirtuin 1 inhibitor | 0.108 0.019 DBMET00534 0.085 0.031 DBMET00614 | DBMET00534 | |
| 0.208 | 0.137 | 0.24 | Gastrin inhibitor | 0.24 0.092 DBMET00614 | DBMET00614 | |
| 0.077 | 0.006 | 0.125 | Arginase inhibitor | 0.077 0.006 DBMET00534 0.125 0.003 DBMET00587 0.06 0.01 DBMET00614 | DBMET00587 | |
| 0.147 | 0.077 | 0.269 | Heat shock protein 90 antagonist | 0.269 0.015 DBMET00534 0.129 0.099 DBMET00614 | DBMET00534 | |
| 0.12 | 0.05 | 0.12 | Alpha 2c adrenoreceptor antagonist | 0.095 0.07 DBMET00534 0.089 0.076 DBMET00614 | ||
| 0.11 | 0.04 | 0.175 | Protein kinase C zeta inhibitor | 0.111 0.039 DBMET00534 0.175 0.015 DBMET00565 0.175 0.015 DBMET00573 0.083 0.079 DBMET00614 | DBMET00573 | |
| 0.13 | 0.061 | 0.195 | Papain-like protease (SARS coronavirus) inhibitor | 0.195 0.012 DBMET00534 | DBMET00534 | |
| 0.081 | 0.012 | 0.083 | 5 Hydroxytryptamine 7 agonist | 0.066 0.023 DBMET00534 0.083 0.012 DBMET00614 | DBMET00614 | |
| 0.072 | 0.004 | 0.085 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.085 0.004 DBMET00534 0.047 0.019 DBMET00565 0.047 0.019 DBMET00573 0.054 0.011 DBMET00614 | DBMET00534 | |
| 0.073 | 0.005 | 0.073 | Catechol O-methyltransferase inhibitor | 0.054 0.008 DBMET00534 0.045 0.011 DBMET00565 0.045 0.011 DBMET00573 0.055 0.007 DBMET00614 | ||
| 0.101 | 0.034 | 0.101 | Opioid kappa receptor antagonist | 0.074 0.068 DBMET00534 | ||
| 0.118 | 0.051 | 0.34 | AMP-activated protein kinase stimulant | 0.14 0.035 DBMET00534 0.34 0.004 DBMET00587 | DBMET00587 | |
| 0.082 | 0.016 | 0.083 | Botulinum neurotoxin type A inhibitor | 0.083 0.015 DBMET00534 0.062 0.035 DBMET00614 | DBMET00534 | |
| 0.082 | 0.017 | 0.088 | Histone deacetylase SIRT3 inhibitor | 0.083 0.016 DBMET00534 0.088 0.014 DBMET00614 | DBMET00614 | |
| 0.084 | 0.018 | 0.15 | Heat shock protein 90 beta antagonist | 0.15 0.005 DBMET00534 0.056 0.046 DBMET00614 | DBMET00534 | |
| 0.085 | 0.02 | 0.085 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 DBMET00534 0.076 0.024 DBMET00614 | ||
| 0.101 | 0.036 | 0.102 | Glutathione S-transferase inhibitor | 0.102 0.035 DBMET00534 0.08 0.062 DBMET00614 | DBMET00534 | |
| 0.113 | 0.048 | 0.113 | Antiadrenergic | 0.077 0.074 DBMET00534 | ||
| 0.154 | 0.09 | 0.154 | Antipruritic | 0.135 0.113 DBMET00614 | ||
| 0.073 | 0.009 | 0.092 | Histamine H2 receptor agonist | 0.055 0.018 DBMET00534 0.092 0.005 DBMET00614 | DBMET00614 | |
| 0.083 | 0.021 | 0.083 | Ornithine carbamoyltransferase inhibitor | 0.078 0.022 DBMET00534 0.073 0.024 DBMET00614 | ||
| 0.102 | 0.04 | 0.112 | Glutamate release inhibitor | 0.112 0.028 DBMET00534 0.1 0.042 DBMET00587 0.103 0.038 DBMET00614 | DBMET00534 | |
| 0.121 | 0.059 | 0.132 | 5 Hydroxytryptamine 2B antagonist | 0.118 0.062 DBMET00534 0.132 0.05 DBMET00614 | DBMET00614 | |
| 0.069 | 0.007 | 0.069 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 DBMET00534 0.044 0.021 DBMET00614 | ||
| 0.078 | 0.017 | 0.086 | Calcium channel P-type blocker | 0.086 0.011 DBMET00614 | DBMET00614 | |
| 0.071 | 0.01 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.055 0.037 DBMET00534 0.07 0.011 DBMET00614 | ||
| 0.071 | 0.011 | 0.071 | Leukotriene A4 hydrolase inhibitor | 0.068 0.012 DBMET00614 | ||
| 0.071 | 0.011 | 0.192 | Mannosidase inhibitor | 0.062 0.016 DBMET00534 0.093 0.006 DBMET00565 0.093 0.006 DBMET00573 0.192 0.003 DBMET00587 0.056 0.02 DBMET00614 | DBMET00587 | |
| 0.064 | 0.004 | 0.092 | Dopamine D1 agonist | 0.059 0.004 DBMET00534 0.092 0.003 DBMET00565 0.092 0.003 DBMET00573 0.052 0.004 DBMET00587 0.023 0.016 DBMET00614 | DBMET00573 | |
| 0.077 | 0.017 | 0.125 | Leukotriene B4 antagonist | 0.095 0.011 DBMET00534 0.086 0.014 DBMET00565 0.086 0.014 DBMET00573 0.125 0.007 DBMET00587 0.054 0.036 DBMET00614 | DBMET00587 | |
| 0.088 | 0.029 | 0.096 | Dopamine D1 antagonist | 0.096 0.026 DBMET00534 | DBMET00534 | |
| 0.074 | 0.016 | 0.075 | Aconitate hydratase inhibitor | 0.065 0.022 DBMET00534 0.075 0.016 DBMET00614 | DBMET00614 | |
| 0.071 | 0.013 | 0.075 | Carbonic anhydrase II stimulant | 0.064 0.019 DBMET00534 0.048 0.045 DBMET00565 0.048 0.045 DBMET00573 0.075 0.011 DBMET00614 | DBMET00614 | |
| 0.163 | 0.105 | 0.174 | Pyruvate kinase inhibitor | 0.174 0.097 DBMET00534 | DBMET00534 | |
| 0.071 | 0.013 | 0.071 | Squalene epoxidase inhibitor | 0.058 0.023 DBMET00534 0.051 0.033 DBMET00614 | ||
| 0.067 | 0.009 | 0.067 | Geranyltranstransferase inhibitor | 0.051 0.022 DBMET00534 0.059 0.014 DBMET00614 | ||
| 0.089 | 0.031 | 0.089 | Sphingosine 1-phosphate receptor 4 agonist | 0.083 0.035 DBMET00614 | ||
| 0.072 | 0.015 | 0.147 | Alpha-mannosidase inhibitor | 0.068 0.018 DBMET00534 0.088 0.009 DBMET00565 0.088 0.009 DBMET00573 0.147 0.004 DBMET00587 0.06 0.026 DBMET00614 | DBMET00587 | |
| 0.072 | 0.015 | 0.072 | Ryanodine receptor antagonist | 0.064 0.027 DBMET00534 0.065 0.025 DBMET00614 | ||
| 0.064 | 0.008 | 0.064 | Sphingosine kinase 1 inhibitor | 0.058 0.01 DBMET00534 0.044 0.024 DBMET00614 | ||
| 0.106 | 0.05 | 0.106 | Adrenaline antagonist | |||
| 0.078 | 0.022 | 0.08 | Urokinase inhibitor | 0.08 0.021 DBMET00534 0.075 0.023 DBMET00614 | DBMET00534 | |
| 0.062 | 0.006 | 0.062 | Glutamate (mGluR8) agonist | 0.06 0.007 DBMET00534 0.052 0.01 DBMET00614 | ||
| 0.091 | 0.035 | 0.091 | CC chemokine 5 receptor agonist | 0.079 0.068 DBMET00565 0.079 0.068 DBMET00573 0.08 0.064 DBMET00614 | ||
| 0.084 | 0.029 | 0.385 | HIV-1 integrase (Strand Transfer) inhibitor | 0.103 0.021 DBMET00534 0.385 0.004 DBMET00565 0.385 0.004 DBMET00573 0.062 0.04 DBMET00587 | DBMET00573 | |
| 0.064 | 0.009 | 0.071 | Sirtuin 2 inhibitor | 0.058 0.01 DBMET00534 0.071 0.007 DBMET00614 | DBMET00614 | |
| 0.132 | 0.077 | 0.134 | Nav1.6 sodium channel blocker | 0.134 0.075 DBMET00614 | DBMET00614 | |
| 0.088 | 0.033 | 0.148 | HIV-1 integrase inhibitor | 0.092 0.03 DBMET00534 0.148 0.009 DBMET00565 0.148 0.009 DBMET00573 | DBMET00573 | |
| 0.146 | 0.091 | 0.241 | Heat shock protein 90 alpha antagonist | 0.241 0.03 DBMET00534 0.131 0.109 DBMET00614 | DBMET00534 | |
| 0.079 | 0.025 | 0.08 | Glutamate (mGluR6) antagonist | 0.074 0.032 DBMET00534 0.08 0.024 DBMET00614 | DBMET00614 | |
| 0.147 | 0.093 | 0.147 | Protein kinase (CK1) gamma 3 inhibitor | 0.128 0.116 DBMET00534 0.133 0.11 DBMET00614 | ||
| 0.076 | 0.022 | 0.076 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.065 0.034 DBMET00534 0.056 0.053 DBMET00614 | ||
| 0.061 | 0.008 | 0.07 | 5 Hydroxytryptamine 2B agonist | 0.053 0.012 DBMET00534 0.07 0.006 DBMET00614 | DBMET00614 | |
| 0.1 | 0.048 | 0.142 | Calcium antagonist | 0.142 0.025 DBMET00614 | DBMET00614 | |
| 0.065 | 0.013 | 0.065 | Oxytocin agonist | 0.057 0.019 DBMET00534 0.058 0.019 DBMET00614 | ||
| 0.068 | 0.016 | 0.068 | NMDA receptor subunit 3B antagonist | 0.043 0.031 DBMET00534 | ||
| 0.071 | 0.021 | 0.082 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.082 0.015 DBMET00534 0.055 0.035 DBMET00614 | DBMET00534 | |
| 0.062 | 0.011 | 0.066 | Carbonic anhydrase I stimulant | 0.051 0.016 DBMET00534 0.066 0.01 DBMET00614 | DBMET00614 | |
| 0.137 | 0.087 | 0.327 | NOS3 expression enhancer | 0.128 0.101 DBMET00534 0.327 0.014 DBMET00587 | DBMET00587 | |
| 0.066 | 0.016 | 0.066 | Carbonic anhydrase IV inhibitor | 0.048 0.026 DBMET00534 0.055 0.022 DBMET00614 | ||
| 0.072 | 0.023 | 0.119 | Alpha tubulin antagonist | 0.119 0.013 DBMET00534 | DBMET00534 | |
| 0.078 | 0.03 | 0.081 | NMDA receptor glycine site agonist | 0.056 0.05 DBMET00534 0.081 0.027 DBMET00614 | DBMET00614 | |
| 0.057 | 0.01 | 0.068 | Histamine H1 receptor agonist | 0.052 0.015 DBMET00534 0.068 0.005 DBMET00614 | DBMET00614 | |
| 0.059 | 0.012 | 0.059 | TRPM8 blocker | 0.048 0.017 DBMET00614 | ||
| 0.079 | 0.032 | 0.084 | Protein kinase C beta inhibitor | 0.084 0.025 DBMET00534 | DBMET00534 | |
| 0.084 | 0.038 | 0.166 | Thrombin inhibitor | 0.076 0.047 DBMET00534 0.166 0.009 DBMET00565 0.166 0.009 DBMET00573 0.084 0.037 DBMET00614 | DBMET00573 | |
| 0.085 | 0.04 | 0.198 | Cathepsin G inhibitor | 0.078 0.045 DBMET00534 0.198 0.016 DBMET00565 0.198 0.016 DBMET00573 0.081 0.043 DBMET00614 | DBMET00573 | |
| 0.057 | 0.013 | 0.057 | Dihydropteroate synthase inhibitor | 0.053 0.015 DBMET00534 0.047 0.019 DBMET00614 | ||
| 0.119 | 0.074 | 0.198 | DNA repair enzyme inhibitor | 0.111 0.092 DBMET00534 0.198 0.009 DBMET00587 0.111 0.093 DBMET00614 | DBMET00587 | |
| 0.113 | 0.069 | 0.136 | Microtubule formation inhibitor | 0.116 0.066 DBMET00534 0.136 0.046 DBMET00587 0.119 0.061 DBMET00614 | DBMET00587 | |
| 0.094 | 0.05 | 0.115 | 5 Hydroxytryptamine 2C antagonist | 0.083 0.058 DBMET00534 0.115 0.038 DBMET00614 | DBMET00614 | |
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | 0.049 0.015 DBMET00534 0.049 0.015 DBMET00614 | ||
| 0.101 | 0.059 | 0.227 | Xanthine oxidase inhibitor | 0.114 0.05 DBMET00534 0.227 0.015 DBMET00587 | DBMET00587 | |
| 0.073 | 0.031 | 0.074 | Trypsin inhibitor | 0.065 0.039 DBMET00534 0.074 0.03 DBMET00565 0.074 0.03 DBMET00573 0.068 0.035 DBMET00614 | DBMET00573 | |
| 0.047 | 0.004 | 0.047 | Beta 1 adrenoreceptor agonist | 0.044 0.004 DBMET00534 0.021 0.019 DBMET00565 0.021 0.019 DBMET00573 0.025 0.012 DBMET00614 | ||
| 0.089 | 0.047 | 0.096 | Acetylcholine nicotinic antagonist | 0.096 0.042 DBMET00614 | DBMET00614 | |
| 0.053 | 0.011 | 0.053 | Glutamate (mGluR3) antagonist | 0.053 0.011 DBMET00534 0.046 0.015 DBMET00614 | ||
| 0.082 | 0.041 | 0.102 | 5 Hydroxytryptamine 1F antagonist | 0.102 0.03 DBMET00534 0.091 0.036 DBMET00614 | DBMET00534 | |
| 0.1 | 0.059 | 0.114 | Glutamate (mGluR7) agonist | 0.114 0.037 DBMET00614 | DBMET00614 | |
| 0.075 | 0.034 | 0.081 | Glutamate (mGluR7) antagonist | 0.081 0.026 DBMET00614 | DBMET00614 | |
| 0.085 | 0.044 | 0.096 | Interferon agonist | 0.079 0.053 DBMET00534 0.074 0.063 DBMET00565 0.074 0.063 DBMET00573 0.096 0.032 DBMET00587 0.081 0.05 DBMET00614 | DBMET00587 | |
| 0.113 | 0.072 | 0.113 | Proteasome inhibitor | 0.106 0.08 DBMET00534 0.096 0.093 DBMET00614 | ||
| 0.052 | 0.012 | 0.054 | Somatostatin 5 agonist | 0.039 0.02 DBMET00534 0.054 0.011 DBMET00614 | DBMET00614 | |
| 0.135 | 0.095 | 0.382 | Protein-tyrosine phosphatase inhibitor | 0.21 0.043 DBMET00534 0.382 0.01 DBMET00565 0.382 0.01 DBMET00573 0.15 0.078 DBMET00587 0.134 0.096 DBMET00614 | DBMET00573 | |
| 0.066 | 0.026 | 0.106 | Plasmin inhibitor | 0.058 0.029 DBMET00534 0.106 0.017 DBMET00565 0.106 0.017 DBMET00573 0.085 0.021 DBMET00614 | DBMET00573 | |
| 0.113 | 0.073 | 0.271 | Topoisomerase II inhibitor | 0.155 0.047 DBMET00534 0.271 0.021 DBMET00587 0.103 0.083 DBMET00614 | DBMET00587 | |
| 0.042 | 0.003 | 0.042 | Estrogen-related receptor gamma agonist | 0.028 0.004 DBMET00534 0.024 0.006 DBMET00614 | ||
| 0.127 | 0.089 | 0.249 | Farnesoid X receptor antagonist | 0.249 0.012 DBMET00534 | DBMET00534 | |
| 0.098 | 0.06 | 0.098 | Electrolyte absorption antagonist | 0.097 0.061 DBMET00534 0.096 0.064 DBMET00614 | ||
| 0.082 | 0.045 | 0.082 | Analgesic, opioid | |||
| 0.041 | 0.004 | 0.064 | Vanilloid 2 agonist | 0.035 0.006 DBMET00534 0.038 0.004 DBMET00565 0.038 0.004 DBMET00573 0.064 0.002 DBMET00587 0.034 0.006 DBMET00614 | DBMET00587 | |
| 0.071 | 0.034 | 0.132 | Neuraminidase (influenza) inhibitor | 0.087 0.021 DBMET00534 0.132 0.01 DBMET00565 0.132 0.01 DBMET00573 0.126 0.01 DBMET00587 | DBMET00573 | |
| 0.096 | 0.06 | 0.147 | Phosphodiesterase 6D inhibitor | 0.147 0.01 DBMET00587 | DBMET00587 | |
| 0.073 | 0.037 | 0.09 | Exportin-1 inhibitor | 0.09 0.015 DBMET00614 | DBMET00614 | |
| 0.041 | 0.006 | 0.056 | Thyroid hormone agonist | 0.043 0.005 DBMET00534 0.056 0.004 DBMET00565 0.056 0.004 DBMET00573 0.025 0.021 DBMET00614 | DBMET00573 | |
| 0.045 | 0.009 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.011 DBMET00614 | ||
| 0.066 | 0.03 | 0.066 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 DBMET00614 | ||
| 0.061 | 0.027 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET00534 0.052 0.044 DBMET00614 | DBMET00534 | |
| 0.102 | 0.067 | 0.303 | Beta glucuronidase inhibitor | 0.124 0.042 DBMET00534 0.303 0.006 DBMET00587 | DBMET00587 | |
| 0.07 | 0.036 | 0.07 | CXC chemokine 4 receptor antagonist | 0.052 0.049 DBMET00534 0.053 0.048 DBMET00614 | ||
| 0.081 | 0.047 | 0.12 | Catalase inhibitor | 0.12 0.033 DBMET00565 0.12 0.033 DBMET00573 0.066 0.058 DBMET00614 | DBMET00573 | |
| 0.057 | 0.023 | 0.057 | Adenosine deaminase inhibitor | 0.056 0.025 DBMET00534 0.045 0.035 DBMET00587 | ||
| 0.147 | 0.113 | 0.158 | Catenin beta inhibitor | 0.14 0.131 DBMET00534 0.158 0.087 DBMET00614 | DBMET00614 | |
| 0.071 | 0.037 | 0.076 | MDM2 inhibitor | 0.068 0.045 DBMET00534 0.076 0.025 DBMET00614 | DBMET00614 | |
| 0.052 | 0.019 | 0.052 | NMDA receptor subunit 3A antagonist | 0.036 0.029 DBMET00534 | ||
| 0.14 | 0.107 | 0.435 | Dual specificity phosphatase inhibitor | 0.192 0.059 DBMET00534 0.435 0.011 DBMET00565 0.435 0.011 DBMET00573 | DBMET00573 | |
| 0.053 | 0.02 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.051 0.022 DBMET00534 0.068 0.008 DBMET00587 0.041 0.04 DBMET00614 | DBMET00587 | |
| 0.043 | 0.01 | 0.043 | Uridine phosphorylase inhibitor | 0.03 0.018 DBMET00534 0.034 0.015 DBMET00587 0.035 0.014 DBMET00614 | ||
| 0.069 | 0.037 | 0.077 | Interferon inducer | 0.063 0.047 DBMET00534 0.062 0.049 DBMET00565 0.062 0.049 DBMET00573 0.077 0.026 DBMET00587 0.065 0.044 DBMET00614 | DBMET00587 | |
| 0.067 | 0.035 | 0.07 | Transcription factor RelA inhibitor | 0.07 0.03 DBMET00534 0.062 0.049 DBMET00614 | DBMET00534 | |
| 0.06 | 0.028 | 0.08 | Histamine agonist | 0.08 0.014 DBMET00614 | DBMET00614 | |
| 0.057 | 0.026 | 0.057 | Bombesin 2 receptor antagonist | 0.053 0.03 DBMET00534 0.056 0.027 DBMET00614 | ||
| 0.085 | 0.054 | 0.085 | I kappa B kinase inhibitor | |||
| 0.046 | 0.015 | 0.046 | Fumarate hydratase inhibitor | 0.039 0.019 DBMET00534 0.04 0.018 DBMET00614 | ||
| 0.144 | 0.113 | 0.424 | Platelet adhesion inhibitor | 0.156 0.099 DBMET00534 0.366 0.016 DBMET00565 0.366 0.016 DBMET00573 0.424 0.009 DBMET00587 | DBMET00587 | |
| 0.065 | 0.034 | 0.065 | Ribonucleotide reductase inhibitor | 0.052 0.041 DBMET00534 0.047 0.044 DBMET00614 | ||
| 0.037 | 0.006 | 0.037 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DBMET00534 0.027 0.023 DBMET00614 | ||
| 0.078 | 0.047 | 0.085 | Histone deacetylase SIRT2 inhibitor | 0.064 0.062 DBMET00534 0.085 0.041 DBMET00614 | DBMET00614 | |
| 0.04 | 0.01 | 0.04 | Glutamate (mGluR3) agonist | 0.037 0.014 DBMET00534 0.034 0.018 DBMET00614 | ||
| 0.085 | 0.055 | 0.085 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.075 0.073 DBMET00534 | ||
| 0.069 | 0.039 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | 0.066 0.042 DBMET00565 0.066 0.042 DBMET00573 0.085 0.023 DBMET00614 | DBMET00614 | |
| 0.051 | 0.021 | 0.051 | AICAR transformylase inhibitor | 0.042 0.034 DBMET00614 | ||
| 0.246 | 0.217 | 0.759 | Cyclophilin D inhibitor | 0.289 0.173 DBMET00534 0.332 0.136 DBMET00565 0.332 0.136 DBMET00573 0.759 0.009 DBMET00587 | DBMET00587 | |
| 0.073 | 0.044 | 0.116 | Purinergic P2X2 antagonist | 0.116 0.023 DBMET00534 | DBMET00534 | |
| 0.043 | 0.014 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.035 0.023 DBMET00534 0.035 0.022 DBMET00614 | ||
| 0.066 | 0.037 | 0.108 | Neuraminidase inhibitor | 0.09 0.02 DBMET00534 0.094 0.018 DBMET00565 0.094 0.018 DBMET00573 0.108 0.013 DBMET00587 | DBMET00587 | |
| 0.069 | 0.041 | 0.081 | Leukotriene antagonist | 0.081 0.031 DBMET00534 0.06 0.051 DBMET00587 | DBMET00534 | |
| 0.065 | 0.037 | 0.09 | Beta tubulin antagonist | 0.09 0.025 DBMET00534 0.075 0.032 DBMET00614 | DBMET00534 | |
| 0.073 | 0.045 | 0.073 | Amidase inhibitor | |||
| 0.042 | 0.013 | 0.057 | 5 Hydroxytryptamine 1D agonist | 0.057 0.008 DBMET00614 | DBMET00614 | |
| 0.046 | 0.018 | 0.047 | AMPA 4 receptor antagonist | 0.047 0.018 DBMET00534 0.037 0.034 DBMET00614 | DBMET00534 | |
| 0.062 | 0.034 | 0.062 | Alpha 1 adrenoreceptor agonist | 0.055 0.043 DBMET00534 | ||
| 0.091 | 0.064 | 0.13 | Potassium channel (Ca-activated) activator | 0.13 0.035 DBMET00534 | DBMET00534 | |
| 0.058 | 0.031 | 0.099 | Adenine nucleotide translocase inhibitor | 0.099 0.005 DBMET00565 0.099 0.005 DBMET00573 0.076 0.011 DBMET00587 | DBMET00573 | |
| 0.08 | 0.053 | 0.192 | Topoisomerase II alpha inhibitor | 0.116 0.031 DBMET00534 0.192 0.016 DBMET00587 0.079 0.054 DBMET00614 | DBMET00587 | |
| 0.081 | 0.055 | 0.125 | Glycine receptor antagonist | 0.083 0.052 DBMET00534 0.123 0.016 DBMET00565 0.123 0.016 DBMET00573 0.125 0.016 DBMET00587 0.076 0.063 DBMET00614 | DBMET00587 | |
| 0.06 | 0.034 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | 0.049 0.042 DBMET00534 0.045 0.044 DBMET00614 | ||
| 0.065 | 0.039 | 0.065 | I kappa B kinase 2 inhibitor | 0.057 0.052 DBMET00614 | ||
| 0.118 | 0.092 | 0.153 | Cytokine production inhibitor | 0.153 0.06 DBMET00614 | DBMET00614 | |
| 0.054 | 0.028 | 0.059 | Topoisomerase II beta inhibitor | 0.059 0.023 DBMET00534 0.049 0.035 DBMET00614 | DBMET00534 | |
| 0.035 | 0.01 | 0.035 | Purinergic P2Y15 antagonist | 0.034 0.012 DBMET00534 0.031 0.015 DBMET00614 | ||
| 0.091 | 0.066 | 0.115 | Toll-Like receptor 3 antagonist | 0.115 0.033 DBMET00614 | DBMET00614 | |
| 0.048 | 0.023 | 0.052 | Glutamate (mGluR4) antagonist | 0.047 0.024 DBMET00534 0.052 0.019 DBMET00614 | DBMET00614 | |
| 0.045 | 0.02 | 0.045 | GABA uptake inhibitor | 0.035 0.034 DBMET00534 0.037 0.03 DBMET00614 | ||
| 0.053 | 0.028 | 0.063 | Factor III inhibitor | 0.063 0.015 DBMET00587 | DBMET00587 | |
| 0.036 | 0.012 | 0.036 | Lysine carboxypeptidase inhibitor | 0.028 0.017 DBMET00534 0.031 0.015 DBMET00614 | ||
| 0.102 | 0.079 | 0.105 | Electron transport complex I inhibitor | 0.105 0.072 DBMET00534 0.105 0.072 DBMET00614 | DBMET00614 | |
| 0.045 | 0.023 | 0.045 | Somatostatin 1 antagonist | 0.039 0.027 DBMET00614 | ||
| 0.054 | 0.032 | 0.112 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 DBMET00534 0.112 0.005 DBMET00587 | DBMET00587 | |
| 0.122 | 0.1 | 0.122 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.027 | 0.006 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.023 0.01 DBMET00534 0.025 0.008 DBMET00614 | ||
| 0.046 | 0.025 | 0.046 | GABA B receptor antagonist | 0.043 0.028 DBMET00534 0.045 0.026 DBMET00614 | ||
| 0.06 | 0.039 | 0.063 | Plasminogen activator inhibitor | 0.063 0.037 DBMET00534 | DBMET00534 | |
| 0.058 | 0.037 | 0.101 | Carbonic anhydrase II inhibitor | 0.048 0.046 DBMET00534 0.101 0.018 DBMET00565 0.101 0.018 DBMET00573 | DBMET00573 | |
| 0.057 | 0.037 | 0.112 | Carbonic anhydrase I inhibitor | 0.047 0.046 DBMET00534 0.112 0.015 DBMET00565 0.112 0.015 DBMET00573 | DBMET00573 | |
| 0.043 | 0.023 | 0.043 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.034 DBMET00534 | ||
| 0.075 | 0.055 | 0.078 | Nicotinic alpha4beta2 receptor antagonist | 0.078 0.052 DBMET00614 | DBMET00614 | |
| 0.067 | 0.047 | 0.067 | Neuronal nicotinic receptor antagonist | 0.066 0.049 DBMET00614 | ||
| 0.057 | 0.038 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.038 DBMET00534 0.054 0.043 DBMET00587 | ||
| 0.05 | 0.03 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.031 DBMET00534 0.064 0.015 DBMET00587 0.044 0.041 DBMET00614 | DBMET00587 | |
| 0.045 | 0.026 | 0.045 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.03 DBMET00614 | ||
| 0.025 | 0.006 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.022 0.008 DBMET00534 | ||
| 0.11 | 0.091 | 0.138 | Tubulin antagonist | 0.138 0.064 DBMET00534 0.112 0.088 DBMET00614 | DBMET00534 | |
| 0.043 | 0.025 | 0.043 | Plasmepsin II inhibitor | 0.042 0.027 DBMET00614 | ||
| 0.038 | 0.019 | 0.038 | Somatostatin 5 antagonist | |||
| 0.051 | 0.033 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 DBMET00614 | ||
| 0.062 | 0.044 | 0.215 | Carbonic anhydrase inhibitor | 0.215 0.008 DBMET00565 0.215 0.008 DBMET00573 0.058 0.048 DBMET00587 | DBMET00573 | |
| 0.096 | 0.078 | 0.099 | Factor V inhibitor | 0.099 0.072 DBMET00614 | DBMET00614 | |
| 0.111 | 0.094 | 0.111 | Bone formation stimulant | |||
| 0.027 | 0.01 | 0.028 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET00534 0.025 0.013 DBMET00614 | DBMET00534 | |
| 0.072 | 0.055 | 0.077 | Protein kinase B gamma inhibitor | 0.077 0.05 DBMET00614 | DBMET00614 | |
| 0.047 | 0.031 | 0.047 | Opioid mu receptor agonist | |||
| 0.05 | 0.034 | 0.055 | CD45 antagonist | 0.051 0.033 DBMET00534 0.055 0.026 DBMET00614 | DBMET00614 | |
| 0.057 | 0.041 | 0.06 | Aminopeptidase microsomal inhibitor | 0.06 0.039 DBMET00614 | DBMET00614 | |
| 0.056 | 0.04 | 0.056 | Leukotriene C antagonist | 0.056 0.042 DBMET00534 0.056 0.039 DBMET00614 | ||
| 0.053 | 0.037 | 0.053 | Opioid agonist | |||
| 0.035 | 0.02 | 0.044 | Melatonin receptor 1A agonist | 0.044 0.01 DBMET00614 | DBMET00614 | |
| 0.031 | 0.016 | 0.034 | 5 Hydroxytryptamine 6 agonist | 0.028 0.021 DBMET00534 0.034 0.012 DBMET00614 | DBMET00614 | |
| 0.046 | 0.031 | 0.052 | 5 Hydroxytryptamine 2C agonist | 0.047 0.03 DBMET00534 0.052 0.026 DBMET00614 | DBMET00614 | |
| 0.043 | 0.029 | 0.044 | Heme oxygenase inhibitor | 0.044 0.027 DBMET00614 | DBMET00614 | |
| 0.033 | 0.019 | 0.036 | Endothelial nitric-oxide synthase inhibitor | 0.036 0.016 DBMET00614 | DBMET00614 | |
| 0.084 | 0.07 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 DBMET00587 | DBMET00587 | |
| 0.065 | 0.051 | 0.065 | Potassium channel (ATP-sensitive) blocker | |||
| 0.062 | 0.048 | 0.371 | Selectin antagonist | 0.271 0.007 DBMET00565 0.271 0.007 DBMET00573 0.371 0.004 DBMET00587 | DBMET00587 | |
| 0.051 | 0.038 | 0.105 | Carbonic anhydrase XII inhibitor | 0.095 0.021 DBMET00565 0.095 0.021 DBMET00573 0.105 0.019 DBMET00587 | DBMET00587 | |
| 0.043 | 0.03 | 0.048 | Dihydrofolate reductase inhibitor | 0.044 0.03 DBMET00534 0.048 0.022 DBMET00565 0.048 0.022 DBMET00573 0.042 0.035 DBMET00614 | DBMET00573 | |
| 0.024 | 0.011 | 0.033 | Imidazoline I1 receptor antagonist | 0.022 0.013 DBMET00534 0.033 0.006 DBMET00614 | DBMET00614 | |
| 0.042 | 0.029 | 0.042 | Growth hormone release inhibitor | 0.039 0.032 DBMET00614 | ||
| 0.041 | 0.029 | 0.041 | Toll-Like receptor 2 agonist | 0.037 0.033 DBMET00534 | ||
| 0.07 | 0.057 | 0.197 | CDC25A inhibitor | 0.075 0.049 DBMET00534 0.197 0.007 DBMET00565 0.197 0.007 DBMET00573 0.127 0.017 DBMET00614 | DBMET00573 | |
| 0.055 | 0.043 | 0.055 | Dopamine uptake inhibitor | |||
| 0.034 | 0.022 | 0.034 | Melatonin 2 agonist | 0.033 0.023 DBMET00614 | ||
| 0.033 | 0.021 | 0.042 | Dipeptidyl peptidase II inhibitor | 0.042 0.013 DBMET00614 | DBMET00614 | |
| 0.017 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 DBMET00534 0.013 0.01 DBMET00614 | ||
| 0.043 | 0.032 | 0.046 | Glutamate (mGluR group III) antagonist | 0.04 0.038 DBMET00534 0.046 0.027 DBMET00614 | DBMET00614 | |
| 0.06 | 0.049 | 0.079 | 5 Hydroxytryptamine 1D antagonist | 0.079 0.032 DBMET00614 | DBMET00614 | |
| 0.029 | 0.018 | 0.056 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET00534 0.056 0.002 DBMET00565 0.056 0.002 DBMET00573 0.033 0.008 DBMET00587 | DBMET00573 | |
| 0.057 | 0.046 | 0.057 | Acetylcholine M5 receptor antagonist | |||
| 0.028 | 0.017 | 0.029 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.023 DBMET00534 0.029 0.016 DBMET00614 | DBMET00614 | |
| 0.027 | 0.016 | 0.027 | Prostaglandin H2 antagonist | |||
| 0.021 | 0.01 | 0.034 | Antibiotic Anthracycline-like | 0.019 0.014 DBMET00534 0.034 0.003 DBMET00587 0.018 0.015 DBMET00614 | DBMET00587 | |
| 0.037 | 0.026 | 0.041 | Tryptase inhibitor | 0.041 0.021 DBMET00614 | DBMET00614 | |
| 0.024 | 0.013 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.016 | 0.005 | 0.016 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET00534 | ||
| 0.06 | 0.05 | 0.06 | Neutrophil collagenase inhibitor | 0.059 0.052 DBMET00614 | ||
| 0.051 | 0.04 | 0.061 | Protein kinase C epsilon inhibitor | 0.061 0.03 DBMET00534 | DBMET00534 | |
| 0.029 | 0.019 | 0.04 | Melatonin antagonist | 0.028 0.02 DBMET00534 0.04 0.01 DBMET00614 | DBMET00614 | |
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.033 | 0.023 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET00565 0.033 0.023 DBMET00573 0.031 0.027 DBMET00614 | ||
| 0.055 | 0.046 | 0.055 | Pregnane X receptor antagonist | 0.053 0.051 DBMET00614 | ||
| 0.035 | 0.025 | 0.035 | Opioid delta receptor agonist | |||
| 0.035 | 0.027 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.052 | 0.044 | 0.052 | Thromboxane synthase inhibitor | |||
| 0.037 | 0.029 | 0.047 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 DBMET00614 | DBMET00614 | |
| 0.042 | 0.034 | 0.042 | Neurotensin receptor antagonist | |||
| 0.082 | 0.074 | 0.095 | Protein kinase C delta inhibitor | 0.095 0.057 DBMET00534 | DBMET00534 | |
| 0.048 | 0.04 | 0.048 | Prolyl endopeptidase inhibitor | |||
| 0.089 | 0.081 | 0.113 | 5 Hydroxytryptamine 2 antagonist | 0.113 0.063 DBMET00614 | DBMET00614 | |
| 0.027 | 0.02 | 0.027 | Hedgehog signaling activator | |||
| 0.04 | 0.033 | 0.04 | Complement C3a chemotactic receptor antagonist | 0.038 0.034 DBMET00614 | ||
| 0.086 | 0.079 | 0.086 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.127 | 0.12 | 0.423 | Dual specificity phosphatase 3 inhibitor | 0.175 0.077 DBMET00534 0.423 0.012 DBMET00565 0.423 0.012 DBMET00573 | DBMET00573 | |
| 0.03 | 0.025 | 0.034 | ATP citrate lysase inhibitor | 0.034 0.019 DBMET00534 | DBMET00534 | |
| 0.043 | 0.038 | 0.051 | Melanocortin antagonist | 0.042 0.041 DBMET00534 0.051 0.029 DBMET00614 | DBMET00614 | |
| 0.067 | 0.062 | 0.067 | Metalloproteinase-9 inhibitor | |||
| 0.038 | 0.033 | 0.055 | Estradiol 17 beta-dehydrogenase inhibitor | 0.055 0.022 DBMET00534 | DBMET00534 | |
| 0.034 | 0.029 | 0.083 | Antibiotic Aminoglycoside-like | 0.033 0.032 DBMET00534 0.083 0.004 DBMET00587 | DBMET00587 | |
| 0.038 | 0.034 | 0.038 | Dopamine D5 antagonist | |||
| 0.088 | 0.084 | 0.211 | Mediator release inhibitor | 0.211 0.013 DBMET00587 | DBMET00587 | |
| 0.009 | 0.006 | 0.01 | Thyroid hormone beta agonist | 0.01 0.005 DBMET00534 | DBMET00534 | |
| 0.03 | 0.027 | 0.03 | Calcitonin receptor agonist | |||
| 0.096 | 0.093 | 0.099 | Nav1.5 sodium channel blocker | 0.099 0.088 DBMET00614 | DBMET00614 | |
| 0.031 | 0.029 | 0.031 | Kainate receptor 2 antagonist | |||
| 0.05 | 0.048 | 0.061 | Aromatase inhibitor | 0.06 0.041 DBMET00534 0.061 0.04 DBMET00614 | DBMET00614 | |
| 0.034 | 0.032 | 0.036 | Factor VIIa inhibitor | 0.036 0.028 DBMET00534 | DBMET00534 | |
| 0.029 | 0.027 | 0.058 | Estrogen receptor alpha agonist | 0.058 0.015 DBMET00534 | DBMET00534 | |
| 0.085 | 0.083 | 0.132 | Interleukin 12 antagonist | 0.132 0.02 DBMET00587 | DBMET00587 | |
| 0.02 | 0.018 | 0.034 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.034 0.01 DBMET00534 | DBMET00534 | |
| 0.029 | 0.028 | 0.034 | Melatonin agonist | 0.034 0.021 DBMET00614 | DBMET00614 | |
| 0.01 | 0.009 | 0.01 | Beta 3 adrenoreceptor agonist | |||
| 0.051 | 0.05 | 0.061 | Cathepsin L inhibitor | 0.061 0.038 DBMET00614 | DBMET00614 | |
| 0.08 | 0.08 | 0.135 | Breast cancer-resistant protein inhibitor | 0.094 0.061 DBMET00534 0.135 0.03 DBMET00565 0.135 0.03 DBMET00573 | DBMET00573 | |
| 0.015 | 0.014 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.02 | 0.019 | 0.037 | Glutamate (mGluR1a) agonist | 0.02 0.018 DBMET00534 0.037 0.006 DBMET00565 0.037 0.006 DBMET00573 0.02 0.019 DBMET00614 | DBMET00573 | |
| 0.025 | 0.024 | 0.029 | AMPA 3 receptor antagonist | 0.029 0.021 DBMET00534 | DBMET00534 | |
| 0.023 | 0.022 | 0.028 | Melanocortin 5 antagonist | 0.028 0.016 DBMET00614 | DBMET00614 | |
| 0.016 | 0.015 | 0.021 | Telomerase stimulant | 0.016 0.015 DBMET00534 0.021 0.006 DBMET00587 | DBMET00587 | |
| 0.029 | 0.03 | 0.033 | Melatonin 1 agonist | 0.033 0.023 DBMET00614 | DBMET00614 | |
| 0.037 | 0.038 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET00587 | DBMET00587 | |
| 0.013 | 0.015 | 0.014 | Purinergic P2Y1 agonist | 0.014 0.013 DBMET00534 | DBMET00534 | |
| 0.053 | 0.055 | 0.058 | Cyclin D1 inhibitor | 0.058 0.046 DBMET00614 | DBMET00614 | |
| 0.211 | 0.213 | 0.562 | Alpha-glucosidase inhibitor | 0.286 0.167 DBMET00534 0.562 0.063 DBMET00587 | DBMET00587 | |
| 0.019 | 0.021 | 0.045 | Leukotriene B4 receptor 2 antagonist | 0.045 0.005 DBMET00534 0.023 0.014 DBMET00587 | DBMET00534 | |
| 0.014 | 0.017 | 0.018 | Thyroid hormone alpha agonist | 0.018 0.008 DBMET00534 | DBMET00534 | |
| 0.024 | 0.027 | 0.029 | Thrombin receptor antagonist | 0.029 0.019 DBMET00614 | DBMET00614 | |
| 0.091 | 0.095 | 0.25 | Multidrug resistance-associated protein 1 inhibitor | 0.25 0.005 DBMET00565 0.25 0.005 DBMET00573 0.124 0.044 DBMET00587 | DBMET00573 | |
| 0.015 | 0.019 | 0.022 | Melatonin 1 antagonist | 0.022 0.01 DBMET00614 | DBMET00614 | |
| 0.012 | 0.017 | 0.017 | Thyroid hormone alpha antagonist | 0.017 0.009 DBMET00534 | DBMET00534 | |
| 0.077 | 0.082 | 0.086 | Hematopoietic | 0.086 0.057 DBMET00614 | DBMET00614 | |
| 0.022 | 0.027 | 0.093 | Sodium/glucose cotransporter 2 inhibitor | 0.093 0.003 DBMET00587 | DBMET00587 | |
| 0.014 | 0.019 | 0.02 | Histamine H4 receptor agonist | 0.02 0.012 DBMET00614 | DBMET00614 | |
| 0.044 | 0.049 | 0.048 | Cytokine production stimulant | 0.048 0.033 DBMET00587 0.046 0.043 DBMET00614 | DBMET00587 | |
| 0.032 | 0.038 | 0.037 | Kainate receptor antagonist | 0.037 0.031 DBMET00534 | DBMET00534 | |
| 0.038 | 0.044 | 0.042 | Aminopeptidase N inhibitor | 0.042 0.039 DBMET00614 | DBMET00614 | |
| 0.013 | 0.02 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.013 DBMET00534 | DBMET00534 | |
| 0.022 | 0.029 | 0.083 | Sodium/glucose cotransporter inhibitor | 0.083 0.003 DBMET00587 | DBMET00587 | |
| 0.023 | 0.03 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.016 DBMET00614 | DBMET00614 | |
| 0.027 | 0.034 | 0.037 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.037 0.023 DBMET00534 | DBMET00534 | |
| 0.022 | 0.03 | 0.028 | Acid ceramidase inhibitor | 0.028 0.012 DBMET00614 | DBMET00614 | |
| 0.043 | 0.051 | 0.048 | Toll-Like receptor 8 antagonist | 0.048 0.043 DBMET00614 | DBMET00614 | |
| 0.021 | 0.03 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.015 DBMET00565 0.026 0.015 DBMET00573 | DBMET00573 | |
| 0.134 | 0.143 | 0.165 | P-glycoprotein inhibitor | 0.161 0.1 DBMET00534 0.165 0.096 DBMET00587 | DBMET00587 | |
| 0.018 | 0.028 | 0.066 | Protein 30S ribosomal subunit inhibitor | 0.066 0.005 DBMET00587 | DBMET00587 | |
| 0.022 | 0.032 | 0.024 | Complement factor 1s inhibitor | 0.024 0.023 DBMET00614 | DBMET00614 | |
| 0.022 | 0.032 | 0.027 | Nicotinic alpha4beta2 receptor agonist | 0.027 0.022 DBMET00614 | DBMET00614 | |
| 0.037 | 0.047 | 0.199 | Estrogen agonist | 0.059 0.031 DBMET00534 0.199 0.008 DBMET00565 0.199 0.008 DBMET00573 0.05 0.035 DBMET00587 | DBMET00573 | |
| 0.031 | 0.042 | 0.033 | Adenosine uptake inhibitor | 0.033 0.032 DBMET00614 | DBMET00614 | |
| 0.062 | 0.074 | 0.089 | 5 Hydroxytryptamine 2A antagonist | 0.089 0.053 DBMET00614 | DBMET00614 | |
| 0.031 | 0.042 | 0.039 | Histone deacetylase 8 inhibitor | 0.039 0.03 DBMET00614 | DBMET00614 | |
| 0.043 | 0.056 | 0.056 | Protein kinase C eta inhibitor | 0.056 0.037 DBMET00534 | DBMET00534 | |
| 0.017 | 0.032 | 0.114 | Estrogen receptor beta agonist | 0.043 0.021 DBMET00534 0.114 0.01 DBMET00565 0.114 0.01 DBMET00573 | DBMET00573 | |
| 0.051 | 0.068 | 0.101 | CDC25B inhibitor | 0.101 0.015 DBMET00614 | DBMET00614 | |
| 0.043 | 0.059 | 0.359 | NMDA 2B receptor antagonist | 0.359 0.004 DBMET00565 0.359 0.004 DBMET00573 | DBMET00573 | |
| 0.037 | 0.054 | 0.071 | Carbonic anhydrase IX inhibitor | 0.071 0.032 DBMET00565 0.071 0.032 DBMET00573 0.05 0.042 DBMET00587 | DBMET00573 | |
| 0.052 | 0.069 | 0.061 | Corticotropin releasing factor 2 receptor antagonist | 0.061 0.044 DBMET00614 | DBMET00614 | |
| 0.04 | 0.058 | 0.057 | Xanthine dehydrogenase inhibitor | 0.057 0.04 DBMET00534 | DBMET00534 | |
| 0.016 | 0.034 | 0.026 | AMPA 1 receptor antagonist | 0.026 0.022 DBMET00534 | DBMET00534 | |
| 0.021 | 0.039 | 0.028 | Peptide deformylase inhibitor | 0.028 0.023 DBMET00614 | DBMET00614 | |
| 0.049 | 0.069 | 0.063 | 5 Hydroxytryptamine 1B antagonist | 0.063 0.048 DBMET00614 | DBMET00614 | |
| 0.132 | 0.153 | 0.162 | Anticonvulsant | 0.162 0.115 DBMET00614 | DBMET00614 | |
| 0.026 | 0.049 | 0.04 | Cathepsin L1 inhibitor | 0.04 0.027 DBMET00614 | DBMET00614 | |
| 0.074 | 0.097 | 0.119 | Thioredoxin inhibitor | 0.119 0.031 DBMET00587 0.088 0.065 DBMET00614 | DBMET00587 | |
| 0.009 | 0.032 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.006 DBMET00587 | DBMET00587 | |
| 0.016 | 0.039 | 0.057 | Leukotriene B4 receptor 1 antagonist | 0.057 0.005 DBMET00534 | DBMET00534 | |
| 0.038 | 0.062 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.041 DBMET00614 | DBMET00614 | |
| 0.182 | 0.206 | 0.219 | Calpain 2 inhibitor | 0.219 0.172 DBMET00614 | DBMET00614 | |
| 0.081 | 0.105 | 0.105 | GABA receptor agonist | 0.105 0.071 DBMET00614 | DBMET00614 | |
| 0.092 | 0.119 | 0.104 | Acetylcholinesterase inhibitor | 0.104 0.099 DBMET00534 | DBMET00534 | |
| 0.118 | 0.146 | 0.153 | Amyloid beta precursor protein antagonist | 0.153 0.098 DBMET00534 | DBMET00534 | |
| 0.048 | 0.077 | 0.074 | Leukotriene synthesis inhibitor | 0.074 0.041 DBMET00534 | DBMET00534 | |
| 0.053 | 0.082 | 0.082 | Telomerase inhibitor | 0.082 0.043 DBMET00614 | DBMET00614 | |
| 0.078 | 0.107 | 0.223 | Protein-tyrosine phosphatase 1B inhibitor | 0.14 0.05 DBMET00534 0.223 0.023 DBMET00565 0.223 0.023 DBMET00573 0.126 0.059 DBMET00587 | DBMET00573 | |
| 0.062 | 0.094 | 0.086 | Chymotrypsin inhibitor | 0.086 0.047 DBMET00565 0.086 0.047 DBMET00573 | DBMET00573 | |
| 0.069 | 0.103 | 0.163 | Transcription factor NF kappa B stimulant | 0.163 0.013 DBMET00587 | DBMET00587 | |
| 0.025 | 0.059 | 0.18 | Factor Xa inhibitor | 0.18 0.007 DBMET00565 0.18 0.007 DBMET00573 0.057 0.025 DBMET00587 | DBMET00573 | |
| 0.041 | 0.076 | 0.104 | Heparanase inhibitor | 0.065 0.016 DBMET00565 0.065 0.016 DBMET00573 0.104 0.004 DBMET00587 | DBMET00587 | |
| 0.041 | 0.076 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 DBMET00534 | DBMET00534 | |
| 0.121 | 0.165 | 0.159 | 3C-like protease (Human coronavirus) inhibitor | 0.159 0.087 DBMET00614 | DBMET00614 | |
| 0.102 | 0.147 | 0.151 | Mcl-1 antagonist | 0.151 0.088 DBMET00534 | DBMET00534 | |
| 0.067 | 0.115 | 0.087 | Gastric antisecretory | 0.087 0.082 DBMET00565 0.087 0.082 DBMET00573 | DBMET00573 | |
| 0.044 | 0.093 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 DBMET00614 | DBMET00614 | |
| 0.046 | 0.095 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 DBMET00587 | DBMET00587 | |
| 0.024 | 0.073 | 0.064 | Phosphorylase inhibitor | 0.064 0.023 DBMET00587 | DBMET00587 | |
| 0.067 | 0.117 | 0.123 | Uric acid excretion stimulant | 0.082 0.079 DBMET00534 0.123 0.036 DBMET00587 | DBMET00587 | |
| 0.015 | 0.068 | 0.111 | NMDA 2D receptor antagonist | 0.111 0.004 DBMET00565 0.111 0.004 DBMET00573 | DBMET00573 | |
| 0.022 | 0.079 | 0.743 | Cholecystokinin B agonist | 0.743 0.001 DBMET00565 0.743 0.001 DBMET00573 | DBMET00573 | |
| 0.008 | 0.065 | 0.12 | Estrone sulfatase inhibitor | 0.12 0.004 DBMET00565 0.12 0.004 DBMET00573 | DBMET00573 | |
| 0.038 | 0.098 | 0.076 | Lipase inhibitor | 0.076 0.047 DBMET00534 | DBMET00534 | |
| 0.024 | 0.09 | 0.081 | Aldose reductase inhibitor | 0.053 0.037 DBMET00565 0.053 0.037 DBMET00573 0.081 0.023 DBMET00587 | DBMET00587 | |
| 0.031 | 0.11 | 0.117 | Factor IXa inhibitor | 0.117 0.006 DBMET00565 0.117 0.006 DBMET00573 0.093 0.012 DBMET00587 | DBMET00573 | |
| 0.055 | 0.138 | 0.089 | Falcipain inhibitor | 0.089 0.063 DBMET00587 | DBMET00587 | |
| 0.053 | 0.139 | 0.086 | Falcipain 2 inhibitor | 0.086 0.063 DBMET00587 | DBMET00587 | |
| 0.032 | 0.12 | 0.201 | Antineoplastic antibiotic | 0.201 0.021 DBMET00587 | DBMET00587 | |
| 0.007 | 0.099 | 0.031 | Squalene synthetase inhibitor | 0.031 0.023 DBMET00587 | DBMET00587 | |
| 0.041 | 0.141 | 0.096 | Potassium channel large-conductance Ca-activated activator | 0.096 0.026 DBMET00534 | DBMET00534 | |
| 0.029 | 0.133 | 0.075 | Nitric oxide donor | 0.075 0.027 DBMET00587 | DBMET00587 | |
| 0.165 | 0.274 | 0.236 | Ca(v)3.3 blocker | 0.236 0.123 DBMET00614 | DBMET00614 | |
| 0.019 | 0.13 | 0.09 | Leukocyte elastase inhibitor | 0.09 0.011 DBMET00565 0.09 0.011 DBMET00573 | DBMET00573 | |
| 0.052 | 0.167 | 0.127 | DNA intercalator | 0.127 0.054 DBMET00587 | DBMET00587 | |
| 0.023 | 0.144 | 0.066 | Acetylcholine M5 receptor agonist | 0.066 0.048 DBMET00614 | DBMET00614 | |
| 0.021 | 0.147 | 0.103 | Protein 50S ribosomal subunit inhibitor | 0.103 0.012 DBMET00587 | DBMET00587 | |
| 0.061 | 0.196 | 0.146 | T cell inhibitor | 0.085 0.049 DBMET00587 0.146 0.01 DBMET00614 | DBMET00614 | |
| 0.031 | 0.168 | 0.071 | Elastase 1 inhibitor | 0.071 0.046 DBMET00614 | DBMET00614 | |
| 0.005 | 0.159 | 0.769 | Cholecystokinin agonist | 0.769 0.002 DBMET00565 0.769 0.002 DBMET00573 | DBMET00573 | |
| 0.154 | 0.309 | 0.198 | MAP kinase kinase 3 inhibitor | 0.198 0.129 DBMET00614 | DBMET00614 | |
| 0.028 | 0.184 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 DBMET00534 | DBMET00534 | |
| 0.005 | 0.172 | 0.743 | Cholecystokinin A agonist | 0.743 0.001 DBMET00565 0.743 0.001 DBMET00573 | DBMET00573 | |
| 0.18 | 0.363 | 0.746 | Antiinflammatory | 0.321 0.196 DBMET00534 0.303 0.213 DBMET00565 0.303 0.213 DBMET00573 0.746 0.023 DBMET00587 | DBMET00587 | |
| 0.018 | 0.206 | 0.042 | Microtubule stabilization | 0.042 0.038 DBMET00587 | DBMET00587 | |
| 0.058 | 0.25 | 0.231 | Cell adhesion inhibitor | 0.231 0.018 DBMET00587 | DBMET00587 | |
| 0.029 | 0.231 | 0.083 | Histone deacetylase stimulant | 0.083 0.041 DBMET00587 | DBMET00587 | |
| 0.029 | 0.231 | 0.083 | Histone deacetylase SIRT1 stimulant | 0.083 0.041 DBMET00587 | DBMET00587 | |
| 0.097 | 0.311 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 DBMET00587 | DBMET00587 | |
| 0.004 | 0.23 | 0.384 | Cholecystokinin A antagonist | 0.384 0.003 DBMET00565 0.384 0.003 DBMET00573 | DBMET00573 | |
| 0.02 | 0.257 | 0.042 | DNA gyrase subunit A inhibitor | 0.042 0.029 DBMET00534 | DBMET00534 | |
| 0.104 | 0.345 | 0.415 | Immunomodulator | 0.415 0.04 DBMET00587 | DBMET00587 | |
| 0.061 | 0.309 | 0.242 | Hypolipemic | 0.242 0.071 DBMET00587 | DBMET00587 | |
| 0.004 | 0.268 | 0.3 | Cholecystokinin B antagonist | 0.3 0.004 DBMET00565 0.3 0.004 DBMET00573 | DBMET00573 | |
| 0.012 | 0.306 | 0.038 | Purinergic P2Y2 antagonist | 0.038 0.017 DBMET00565 0.038 0.017 DBMET00573 | DBMET00573 | |
| 0.005 | 0.308 | 0.312 | Cholecystokinin antagonist | 0.312 0.004 DBMET00565 0.312 0.004 DBMET00573 | DBMET00573 | |
| 0.029 | 0.346 | 0.105 | Cell adhesion molecule inhibitor | 0.105 0.031 DBMET00587 | DBMET00587 | |
| 0.084 | 0.435 | 0.266 | Toll-Like receptor agonist | 0.266 0.134 DBMET00587 | DBMET00587 | |
| 0.082 | 0.445 | 0.241 | Toll-Like receptor 7 agonist | 0.241 0.155 DBMET00587 | DBMET00587 | |
| 0.007 | 0.396 | 0.048 | Factor XIa inhibitor | 0.048 0.02 DBMET00565 0.048 0.02 DBMET00573 | DBMET00573 | |
| 0.068 | 0.46 | 0.251 | Antiobesity | 0.251 0.155 DBMET00565 0.251 0.155 DBMET00573 | DBMET00573 | |
| 0.053 | 0.481 | 0.429 | Angiogenesis inhibitor | 0.429 0.045 DBMET00565 0.429 0.045 DBMET00573 | DBMET00573 | |
| 0.004 | 0.439 | 0.056 | Factor XI inhibitor | 0.056 0.008 DBMET00565 0.056 0.008 DBMET00573 | DBMET00573 | |
| 0.011 | 0.475 | 0.042 | Elastase 3B inhibitor | 0.042 0.007 DBMET00614 | DBMET00614 | |
| 0.011 | 0.475 | 0.042 | Elastase 3A inhibitor | 0.042 0.007 DBMET00614 | DBMET00614 | |
| 0.011 | 0.475 | 0.042 | Elastase 2B inhibitor | 0.042 0.007 DBMET00614 | DBMET00614 | |
| 0.011 | 0.498 | 0.03 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET00565 0.029 0.013 DBMET00573 0.03 0.012 DBMET00587 | DBMET00587 | |
| 0.008 | 0.521 | 0.107 | Elastase inhibitor | 0.107 0.009 DBMET00565 0.107 0.009 DBMET00573 | DBMET00573 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |